UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB Number:  3235-0582

 

Expires:  March 31, 2018

 

Estimated average burden hours per response........7.2

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811- 06565

 

Tekla Life Sciences Investors

(Exact name of registrant as specified in charter)

 

100 Federal Street, 19th Floor, Boston, MA

 

02110

(Address of principal executive offices)

 

(Zip code)

 

Laura Woodward
Tekla Life Sciences Investors
100 Federal Street, 19th Floor, Boston MA 02110

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617-772-8500

 

Date of fiscal year end:  September 30

 

Date of reporting period:  7/1/15-6/30/16

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 


 

Item 1. Proxy Voting Record.

 


 

Vote Summary

 

ABAXIS, INC.

 

Security

 

002567105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ABAX

 

 

 

Meeting Date

 

28-Oct-2015

Record Date

 

31-Aug-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CLINTON H. SEVERSON

 

 

 

For

 

For

 

 

 

2

VERNON E. ALTMAN

 

 

 

For

 

For

 

 

 

3

RICHARD J BASTIANI, PHD

 

 

 

Withheld

 

Against

 

 

 

4

MICHAEL D. CASEY

 

 

 

Withheld

 

Against

 

 

 

5

HENK J. EVENHUIS

 

 

 

For

 

For

 

 

 

6

PRITHIPAL SINGH, PH.D.

 

 

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE SELECTION OF BURR PILGER MAYER, INC. AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF ABAXIS, INC. FOR THE FISCAL YEAR ENDING MARCH 31, 2016.

 

Management

 

For

 

For

 

 

ACADIA PHARMACEUTICALS INC.

 

Security

 

004225108

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ACAD

 

 

 

Meeting Date

 

10-Jun-2016

Record Date

 

22-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LAURA BREGE

 

 

 

For

 

For

 

 

 

2

STEPHEN DAVIS

 

 

 

For

 

For

 

2.

 

TO APPROVE AN AMENDMENT TO OUR 2004 EMPLOYEE STOCK PURCHASE PLAN TO, AMONG OTHER THINGS, INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 400,000 SHARES.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR 2010 EQUITY INCENTIVE PLAN, AS AMENDED, TO, AMONG OTHER THINGS, INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 3,000,000 SHARES.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

5.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

ACCELERATE DIAGNOSTICS

 

Security

 

00430H102

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

AXDX

 

 

 

Meeting Date

 

06-May-2016

Record Date

 

17-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LAWRENCE MEHREN

 

 

 

For

 

For

 

 

 

2

MARK MILLER

 

 

 

For

 

For

 

 

 

3

JOHN PATIENCE

 

 

 

For

 

For

 

 

 

4

JACK SCHULER

 

 

 

For

 

For

 

 

 

5

MATTHEW STROBECK, PH.D.

 

 

 

For

 

For

 

 

 

6

FRANK J.M. TEN BRINK

 

 

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS

 

Management

 

For

 

For

 

3.

 

TO APPROVE THE ACCELERATE DIAGNOSTICS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT PUBLIC ACCOUNTANTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016

 

Management

 

For

 

For

 

 


 

ADAPTIMMUNE THERAPEUTICS PLC

 

Security

 

00653A107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ADAP

 

 

 

Meeting Date

 

17-Dec-2015

Record Date

 

13-Nov-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

O1

 

TO RECEIVE, CONSIDER AND ADOPT THE DIRECTORS’ AND AUDITOR’S REPORTS AND STATEMENT OF ACCOUNTS FOR THE YEAR ENDED 30 JUNE 2015 AND NOTE THAT THE DIRECTORS DO NOT RECOMMEND PAYMENT OF A DIVIDEND.

 

Management

 

For

 

For

 

O2

 

TO APPROVE THE DIRECTORS’ REMUNERATION REPORT.

 

Management

 

For

 

For

 

O3

 

TO APPROVE THE DIRECTORS’ REMUNERATION POLICY WITH EFFECT FROM AFTER THE END OF THE ANNUAL GENERAL MEETING OF THE COMPANY ON 17 DECEMBER 2015.

 

Management

 

For

 

For

 

O4

 

TO RE-APPOINT KPMG LLP AS AUDITOR.

 

Management

 

For

 

For

 

O5

 

TO AUTHORISE THE DIRECTORS TO DETERMINE THE AUDITOR’S REMUNERATION.

 

Management

 

For

 

For

 

O6

 

TO AUTHORISE THE DIRECTORS UNDER S551 OF THE COMPANIES ACT 2006 (THE “2006 ACT”) TO ALLOT SHARES OR TO GRANT RIGHTS TO SUBSCRIBE FOR OR TO CONVERT ANY SECURITY INTO SHARES.

 

Management

 

For

 

For

 

S7

 

TO AUTHORISE THE DIRECTORS TO ALLOT EQUITY SECURITIES UNDER SECTION 570 OF THE 2006 ACT AS IF SECTION 561(1) OF THE 2006 ACT DID NOT APPLY TO SUCH ALLOTMENT.

 

Management

 

For

 

For

 

 

ADAPTIMMUNE THERAPEUTICS PLC

 

Security

 

00653A107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ADAP

 

 

 

Meeting Date

 

16-Jun-2016

Record Date

 

03-May-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

O1.

 

TO RECEIVE, CONSIDER AND ADOPT THE DIRECTORS’ AND AUDITOR’S REPORTS AND STATEMENT OF ACCOUNTS FOR THE PERIOD ENDED 31 DECEMBER 2015 AND NOTE THAT THE DIRECTORS DO NOT RECOMMEND PAYMENT OF A DIVIDEND.

 

Management

 

For

 

 

 

O2.

 

TO APPROVE THE DIRECTORS’ REMUNERATION REPORT.

 

Management

 

For

 

 

 

O3.

 

TO RE-ELECT JAMES NOBLE AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

 

 

O4.

 

TO RE-ELECT ELLIOTT SIGAL AS A DIRECTOR OF THE COMPANY.

 

Management

 

For

 

 

 

O5.

 

TO RE-APPOINT KPMG LLP AS AUDITOR OF THE COMPANY.

 

Management

 

For

 

 

 

O6.

 

TO AUTHORISE THE AUDIT COMMITTEE TO DETERMINE THE AUDITOR’S REMUNERATION.

 

Management

 

For

 

 

 

S7.

 

TO APPROVE THE AMENDMENT OF THE ARTICLES OF ASSOCIATION OF THE COMPANY.

 

Management

 

For

 

 

 

 

AKORN, INC.

 

Security

 

009728106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

AKRX

 

 

 

Meeting Date

 

01-Jul-2016

Record Date

 

11-May-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN KAPOOR, PHD

 

 

 

For

 

For

 

 

 

2

KENNETH ABRAMOWITZ

 

 

 

For

 

For

 

 

 

3

ADRIENNE GRAVES, PHD

 

 

 

For

 

For

 

 

 

4

RONALD JOHNSON

 

 

 

For

 

For

 

 

 

5

STEVEN MEYER

 

 

 

For

 

For

 

 

 

6

TERRY ALLISON RAPPUHN

 

 

 

For

 

For

 

 

 

7

BRIAN TAMBI

 

 

 

For

 

For

 

 

 

8

ALAN WEINSTEIN

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF BDO USA, LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO APPROVE, THROUGH A NON-BINDING ADVISORY VOTE, THE COMPANY’S EXECUTIVE COMPENSATION PROGRAM AS DESCRIBED IN THE COMPANY’S 2016 PROXY STATEMENT.

 

Management

 

For

 

For

 

 


 

ALEXION PHARMACEUTICALS, INC.

 

Security

 

015351109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ALXN

 

 

 

Meeting Date

 

11-May-2016

Record Date

 

15-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: LEONARD BELL

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: FELIX BAKER

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: DAVID R. BRENNAN

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: M. MICHELE BURNS

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: CHRISTOPHER J. COUGHLIN

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: DAVID L. HALLAL

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: JOHN T. MOLLEN

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: R. DOUGLAS NORBY

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: ALVIN S. PARVEN

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: ANDREAS RUMMELT

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: ANN M. VENEMAN

 

Management

 

For

 

For

 

2.

 

APPROVAL OF A NON-BINDING ADVISORY VOTE OF THE 2015 COMPENSATION PAID TO ALEXION’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF APPOINTMENT BY BOARD OF PRICEWATERHOUSECOOPERS LLP AS ALEXION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

4.

 

TO REQUEST THE BOARD TO AMEND ALEXION’S GOVERNING DOCUMENTS TO GIVE SHAREHOLDERS OWNING 10% OF ALEXION STOCK THE POWER TO CALL A SPECIAL MEETING.

 

Shareholder

 

Against

 

For

 

 

ALKERMES PLC

 

Security

 

G01767105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ALKS

 

 

 

Meeting Date

 

25-May-2016

Record Date

 

17-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: DAVID W. ANSTICE

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: ROBERT A. BREYER

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: WENDY L. DIXON, PH.D.

 

Management

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT AUDITOR OF THE COMPANY AND TO AUTHORIZE THE AUDIT AND RISK COMMITTEE TO SET THE INDEPENDENT AUDITOR’S REMUNERATION ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL).

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE ALKERMES PLC 2011 STOCK OPTION AND INCENTIVE PLAN, AS AMENDED.

 

Management

 

For

 

For

 

5.

 

TO GRANT THE BOARD THE AUTHORITY TO ISSUE SHARES UNDER IRISH LAW.

 

Management

 

For

 

For

 

6A.

 

TO APPROVE CERTAIN AMENDMENTS TO THE COMPANY’S ARTICLES OF ASSOCIATION THAT ADDRESS THE ADOPTION OF THE IRISH COMPANIES ACT 2014.

 

Management

 

For

 

For

 

6B.

 

TO APPROVE CERTAIN AMENDMENTS TO THE COMPANY’S MEMORANDUM OF ASSOCIATION THAT ADDRESS THE ADOPTION OF THE IRISH COMPANIES ACT 2014.

 

Management

 

For

 

For

 

7.

 

TO GRANT THE BOARD THE AUTHORITY TO OPT-OUT OF STATUTORY PRE-EMPTION RIGHTS UNDER IRISH LAW.

 

Management

 

For

 

For

 

 


 

ALLERGAN PLC

 

Security

 

G0177J108

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

AGN

 

 

 

Meeting Date

 

05-May-2016

Record Date

 

07-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

NESLI BASGOZ, M.D.

 

 

 

For

 

For

 

 

 

2

PAUL M. BISARO

 

 

 

For

 

For

 

 

 

3

JAMES H. BLOEM

 

 

 

For

 

For

 

 

 

4

CHRISTOPHER W. BODINE

 

 

 

For

 

For

 

 

 

5

CHRISTOPHER J. COUGHLIN

 

 

 

For

 

For

 

 

 

6

MICHAEL R. GALLAGHER

 

 

 

For

 

For

 

 

 

7

CATHERINE M. KLEMA

 

 

 

For

 

For

 

 

 

8

PETER J. MCDONNELL, M.D

 

 

 

For

 

For

 

 

 

9

PATRICK J. O’SULLIVAN

 

 

 

For

 

For

 

 

 

10

BRENTON L. SAUNDERS

 

 

 

For

 

For

 

 

 

11

RONALD R. TAYLOR

 

 

 

For

 

For

 

 

 

12

FRED G. WEISS

 

 

 

For

 

For

 

2.

 

TO APPROVE, IN A NON-BINDING VOTE, NAMED EXECUTIVE OFFICER COMPENSATION

 

Management

 

For

 

For

 

3.

 

TO RATIFY, IN A NON-BINDING VOTE, THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016 AND TO AUTHORIZE, IN A BINDING VOTE, THE BOARD OF DIRECTORS, ACTING THROUGH THE AUDIT AND COMPLIANCE COMMITTEE, TO DETERMINE PRICEWATERHOUSECOOPERS LLP’S REMUNERATION

 

Management

 

For

 

For

 

4A.

 

TO APPROVE THE AMENDMENT OF THE COMPANY’S: MEMORANDUM OF ASSOCIATION TO MAKE CERTAIN ADMINISTRATIVE AMENDMENTS

 

Management

 

For

 

For

 

4B.

 

TO APPROVE THE AMENDMENT OF THE COMPANY’S: ARTICLES OF ASSOCIATION TO MAKE CERTAIN ADMINISTRATIVE AMENDMENTS

 

Management

 

For

 

For

 

5A.

 

TO APPROVE THE AMENDMENT OF THE COMPANY’S ARTICLES OF ASSOCIATION IN ORDER TO: PROVIDE FOR A PLURALITY VOTING STANDARD IN THE EVENT OF A CONTESTED ELECTION

 

Management

 

For

 

For

 

5B.

 

TO APPROVE THE AMENDMENT OF THE COMPANY’S ARTICLES OF ASSOCIATION IN ORDER TO: GRANT THE BOARD OF DIRECTORS SOLE AUTHORITY TO DETERMINE ITS SIZE

 

Management

 

For

 

For

 

6.

 

TO APPROVE THE REDUCTION OF COMPANY CAPITAL

 

Management

 

For

 

For

 

7.

 

TO CONSIDER A SHAREHOLDER PROPOSAL REGARDING AN ANNUAL REPORT ON LOBBYING ACTIVITIES, IF PROPERLY PRESENTED AT THE MEETING

 

Shareholder

 

Against

 

For

 

8.

 

TO CONSIDER A SHAREHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIRMAN, IF PROPERLY PRESENTED AT THE MEETING

 

Shareholder

 

Against

 

For

 

 

ALLIQUA BIOMEDICAL, INC.

 

Security

 

019621200

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ALQA

 

 

 

Meeting Date

 

06-May-2016

Record Date

 

11-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DAVID JOHNSON

 

 

 

For

 

For

 

 

 

2

WINSTON KUNG

 

 

 

For

 

For

 

 

 

3

JOSEPH LEONE

 

 

 

For

 

For

 

 

 

4

GARY RESTANI

 

 

 

For

 

For

 

 

 

5

JEFFREY SKLAR

 

 

 

For

 

For

 

 

 

6

MARK WAGNER

 

 

 

For

 

For

 

 

 

7

JEROME ZELDIS, MD, PHD.

 

 

 

For

 

For

 

2.

 

APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 45,714,286 TO 95,000,000.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF THE APPOINTMENT OF MARCUM LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

ALNYLAM PHARMACEUTICALS, INC.

 

Security

 

02043Q107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ALNY

 

 

 

Meeting Date

 

03-May-2016

Record Date

 

11-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF CLASS III DIRECTOR: STEVEN M. PAUL, M.D.

 

Management

 

For

 

For

 

1.2

 

ELECTION OF CLASS III DIRECTOR: AMY W. SCHULMAN

 

Management

 

For

 

For

 

1.3

 

ELECTION OF CLASS III DIRECTOR: KEVIN P. STARR

 

Management

 

For

 

For

 

2.

 

TO APPROVE, IN A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF ALNYLAM’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS ALNYLAM’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 


 

ALTERG, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

1-Feb-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

WAIVER OF REQUIREMENT FOR AUDITED FINANCIAL STATEMENTS

 

Management

 

For

 

For

 

2

 

ADDITIONAL PROVISIONS

 

Management

 

For

 

For

 

 

AMGEN INC.

 

Security

 

031162100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

AMGN

 

 

 

Meeting Date

 

19-May-2016

Record Date

 

21-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: DR. DAVID BALTIMORE

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: MR. FRANK J. BIONDI, JR.

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: MR. ROBERT A. BRADWAY

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: MR. FRANCOIS DE CARBONNEL

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: MR. ROBERT A. ECKERT

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: MR. GREG C. GARLAND

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: MR. FRED HASSAN

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: DR. REBECCA M. HENDERSON

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: MR. FRANK C. HERRINGER

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: DR. TYLER JACKS

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: MS. JUDITH C. PELHAM

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: DR. RONALD D. SUGAR

 

Management

 

For

 

For

 

1M.

 

ELECTION OF DIRECTOR FOR A TERM EXPIRING AT 2017: DR. R. SANDERS WILLIAMS

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

STOCKHOLDER PROPOSAL TO CHANGE THE VOTING STANDARD APPLICABLE TO NON-BINDING PROPOSALS SUBMITTED BY STOCKHOLDERS.

 

Shareholder

 

Against

 

For

 

 

AMICUS THERAPEUTICS, INC.

 

Security

 

03152W109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

FOLD

 

 

 

Meeting Date

 

09-Jun-2016

Record Date

 

15-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN F. CROWLEY

 

 

 

For

 

For

 

 

 

2

MARGARET G. MCGLYNN RPH

 

 

 

For

 

For

 

 

 

3

MICHAEL G. RAAB

 

 

 

For

 

For

 

 

 

4

GLENN P. SBLENDORIO

 

 

 

For

 

For

 

2.

 

APPROVE THE AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

APPROVE THE ISSUANCE OF SHARES OF THE COMPANY’S COMMON STOCK IN CONNECTION WITH A SPECIFIC MILESTONE PAYMENT THAT MAY BECOME PAYABLE TO THE FORMER SCIODERM STOCKHOLDERS, IN ACCORDANCE WITH THE MARKETPLACE RULES OF THE NASDAQ STOCK MARKET, LLC.

 

Management

 

For

 

For

 

4.

 

RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

5.

 

APPROVE, ON AN ADVISORY BASIS, THE COMPANY’S EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 


 

ANACOR PHARMACEUTICALS INC

 

Security

 

032420101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ANAC

 

 

 

Meeting Date

 

07-Jun-2016

Record Date

 

12-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

PAUL L. BERNS

 

 

 

For

 

For

 

 

 

2

LUCY SHAPIRO, PH.D.

 

 

 

For

 

For

 

 

 

3

WENDELL WIERENGA, PH.D.

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO RE-APPROVE THE SECTION 162(M) PERFORMANCE GOALS UNDER THE COMPANY’S 2010 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

ARDELYX, INC

 

Security

 

039697107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ARDX

 

 

 

Meeting Date

 

02-Jun-2016

Record Date

 

08-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DAVID MOTT

 

 

 

For

 

For

 

 

 

2

MICHAEL RAAB

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF ERNST & YOUNG, LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

ARIAD PHARMACEUTICALS, INC.

 

Security

 

04033A100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ARIA

 

 

 

Meeting Date

 

21-Jul-2016

Record Date

 

25-May-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

TO ADOPT AN AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION TO DECLASSIFY THE BOARD OF DIRECTORS AND PROVIDE FOR THE ANNUAL ELECTION OF DIRECTORS.

 

Management

 

For

 

For

 

2A.

 

TO ELECT CLASS 1 DIRECTOR TO SERVE ON OUR BOARD OF DIRECTORS: ALEXANDER J. DENNER, PH.D.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2016.

 

Management

 

For

 

For

 

 


 

AURIS MEDICAL HOLDING AG

 

Security

 

H03579101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

EARS

 

 

 

Meeting Date

 

08-Apr-2016

Record Date

 

10-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

G1

 

GENERAL INSTRUCTIONS ON THE PROPOSALS OF THE BOARD OF DIRECTORS

 

Management

 

For

 

For

 

G2

 

GENERAL INSTRUCTIONS ON NEW PROPOSALS OF THE BOARD OF DIRECTORS/ NEW AGENDA ITEMS

 

Management

 

For

 

For

 

S1

 

APPROVAL OF THE ANNUAL REPORT, THE FINANCIAL STATEMENTS AND THE GROUP CONSOLIDATED FINANCIAL STATEMENTS FOR THE 2015 FINANCIAL YEAR

 

Management

 

For

 

For

 

S2

 

DISCHARGE OF THE MEMBERS OF THE BOARD AND THE PERSONS ENTRUSTED WITH THE COMPANY’S MANAGEMENT

 

Management

 

For

 

For

 

S3

 

APPROPRIATION OF FINANCIAL RESULTS

 

Management

 

For

 

For

 

S4A

 

INCREASE AND AMENDMENT OF THE AUTHORIZED SHARE CAPITAL

 

Management

 

For

 

For

 

S4B

 

INCREASE AND AMENDMENT OF THE CONDITIONAL SHARE CAPITAL

 

Management

 

For

 

For

 

S4C

 

CANCELLATION OF ARTICLE 5 OF THE ARTICLES OF ASSOCIATION

 

Management

 

For

 

For

 

S5A

 

APPROVAL OF THE COMPENSATION OF THE BOARD OF DIRECTORS

 

Management

 

For

 

For

 

S5B

 

APPROVAL OF THE COMPENSATION OF THE MEMBERS OF THE EXECUTIVE MANAGEMENT COMMITTEE FOR THE 2015 FINANCIAL YEAR

 

Management

 

For

 

For

 

S5C

 

APPROVAL OF THE COMPENSATION OF THE MEMBERS OF THE EXECUTIVE MANAGEMENT COMMITTEE FOR THE 2017 FINANCIAL YEAR

 

Management

 

For

 

For

 

S6A

 

RE-ELECTION OF THOMAS MEYER AS MEMBER AND CHAIRMAN

 

Management

 

For

 

For

 

S6B

 

RE-ELECTION OF JAMES I. HEALY AS MEMBER OF THE BOARD

 

Management

 

For

 

For

 

S6C

 

RE-ELECTION OF WOLFGANG ARNOLD AS MEMBER OF THE BOARD

 

Management

 

For

 

For

 

S6D

 

RE-ELECTION OF OLIVER KUBLI AS MEMBER OF THE BOARD

 

Management

 

For

 

For

 

S6E

 

RE-ELECTION OF BERNDT A. MODIG AS MEMBER OF THE BOARD

 

Management

 

For

 

For

 

S6F

 

RE-ELECTION OF ANTOINE PAPIERNIK AS MEMBER OF THE BOARD

 

Management

 

For

 

For

 

S6G

 

RE-ELECTION OF CALVIN W. ROBERTS AS MEMBER OF THE BOARD

 

Management

 

For

 

For

 

S6H

 

ELECTION OF ARMANDO ANIDO AS MEMBER OF THE BOARD

 

Management

 

For

 

For

 

S7A

 

RE-ELECTION OF JAMES I. HEALY AS MEMBER OF THE COMPENSATION COMMITTEE

 

Management

 

For

 

For

 

S7B

 

RE-ELECTION OF ANTOINE PAPIERNIK AS MEMBER OF THE COMPENSATION COMMITTEE

 

Management

 

For

 

For

 

S7C

 

ELECTION OF ARMANDO ANIDO AS MEMBER OF THE COMPENSATION COMMITTEE

 

Management

 

For

 

For

 

S8

 

RE-ELECTION OF DELOITTE AG AS AUDITORS

 

Management

 

For

 

For

 

S9

 

RE-ELECTION OF THE INDEPENDENT PROXY SANDRO G. TOBLER

 

Management

 

For

 

For

 

 

BELLICUM PHARMACEUTICALS INC

 

Security

 

079481107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BLCM

 

 

 

Meeting Date

 

15-Jun-2016

Record Date

 

18-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JAMES F. BROWN

 

 

 

For

 

For

 

 

 

2

KEVIN M. SLAWIN, M.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

BIODELIVERY SCIENCES INTERNATIONAL, INC.

 

Security

 

09060J106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BDSI

 

 

 

Meeting Date

 

16-Jul-2015

Record Date

 

05-Jun-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

FRANCIS E. O’DONNELL JR

 

 

 

For

 

For

 

 

 

2

SAMUEL P. SEARS, JR.

 

 

 

For

 

For

 

 

 

3

BARRY I. FEINBERG

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT BY THE AUDIT COMMITTEE OF THE COMPANY’S BOARD OF DIRECTORS OF CHERRY BEKAERT LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO THE 2011 EQUITY INCENTIVE PLAN TO, AMONG OTHER MATTERS, INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE 2011 PLAN FROM 8,800,000 TO 11,050,000.

 

Management

 

For

 

For

 

4.

 

IN THEIR DISCRETION, UPON THE TRANSACTION OF ANY OTHER MATTERS WHICH MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF.

 

Management

 

For

 

For

 

 


 

BIOGEN INC.

 

Security

 

09062X103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BIIB

 

 

 

Meeting Date

 

08-Jun-2016

Record Date

 

11-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: ALEXANDER J. DENNER

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: CAROLINE D. DORSA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: NANCY L. LEAMING

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: RICHARD C. MULLIGAN

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: ROBERT W. PANGIA

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: BRIAN S. POSNER

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: ERIC K. ROWINSKY

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: GEORGE A. SCANGOS

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: LYNN SCHENK

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: STEPHEN A. SHERWIN

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS BIOGEN INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

SAY ON PAY - TO APPROVE AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 

BIOMARIN PHARMACEUTICAL INC.

 

Security

 

09061G101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BMRN

 

 

 

Meeting Date

 

06-Jun-2016

Record Date

 

11-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JEAN-JACQUES BIENAIME

 

 

 

For

 

For

 

 

 

2

MICHAEL GREY

 

 

 

For

 

For

 

 

 

3

ELAINE J. HERON

 

 

 

For

 

For

 

 

 

4

V. BRYAN LAWLIS

 

 

 

For

 

For

 

 

 

5

ALAN J. LEWIS

 

 

 

For

 

For

 

 

 

6

RICHARD A. MEIER

 

 

 

For

 

For

 

 

 

7

DAVID PYOTT

 

 

 

For

 

For

 

 

 

8

DENNIS J. SLAMON

 

 

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF BIOMARIN’S NAMED EXECUTIVE OFFICERS AS DEFINED AND DISCLOSED IN ITS PROXY STATEMENT.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE SELECTION OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR BIOMARIN FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

4.

 

A STOCKHOLDER PROPOSAL REQUESTING THAT BIOMARIN ISSUE A SUSTAINABILITY REPORT DESCRIBING BIOMARIN’S ENVIRONMENTAL, SOCIAL AND GOVERNANCE PERFORMANCE, IF PROPERLY PRESENTED AT BIOMARIN’S ANNUAL MEETING OF STOCKHOLDERS.

 

Shareholder

 

Against

 

For

 

 

BLUEBIRD BIO INC.

 

Security

 

09609G100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BLUE

 

 

 

Meeting Date

 

02-Jun-2016

Record Date

 

08-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

WENDY DIXON

 

 

 

For

 

For

 

 

 

2

JAMES MANDELL

 

 

 

For

 

For

 

 

 

3

DAVID SCHENKEIN

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE ON EXECUTIVE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 


 

CARDIOKINETIX, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

11-Apr-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

ELECTION OF DANIEL OMSTEAD TO THE BOARD OF DIRECTORS

 

Management

 

For

 

For

 

2

 

OMNIBUS RESOLUTIONS

 

Management

 

For

 

For

 

 

CELATOR PHARMACEUTICALS, INC.

 

Security

 

15089R102

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CPXX

 

 

 

Meeting Date

 

06-Jun-2016

Record Date

 

22-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MICHAEL R. DOUGHERTY

 

 

 

For

 

For

 

 

 

2

SCOTT T. JACKSON

 

 

 

For

 

For

 

 

 

3

JEAN-PIERRE BIZZARI

 

 

 

For

 

For

 

 

 

4

RICHARD S. KOLLENDER

 

 

 

For

 

For

 

 

 

5

JOSEPH M. LOBACKI

 

 

 

For

 

For

 

 

 

6

JOSEPH A. MOLLICA

 

 

 

For

 

For

 

 

 

7

SCOTT MORENSTEIN

 

 

 

For

 

For

 

 

 

8

NICOLE VITULLO

 

 

 

For

 

For

 

2.

 

THE RATIFICATION OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

CELGENE CORPORATION

 

Security

 

151020104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CELG

 

 

 

Meeting Date

 

15-Jun-2016

Record Date

 

18-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. HUGIN

 

 

 

For

 

For

 

 

 

2

MARK J. ALLES

 

 

 

For

 

For

 

 

 

3

RICHARD W BARKER D PHIL

 

 

 

For

 

For

 

 

 

4

MICHAEL W. BONNEY

 

 

 

For

 

For

 

 

 

5

MICHAEL D. CASEY

 

 

 

For

 

For

 

 

 

6

CARRIE S. COX

 

 

 

For

 

For

 

 

 

7

JACQUALYN A. FOUSE, PHD

 

 

 

For

 

For

 

 

 

8

MICHAEL A. FRIEDMAN, MD

 

 

 

For

 

For

 

 

 

9

JULIA A. HALLER, M.D.

 

 

 

For

 

For

 

 

 

10

GILLA S. KAPLAN, PH.D.

 

 

 

For

 

For

 

 

 

11

JAMES J. LOUGHLIN

 

 

 

For

 

For

 

 

 

12

ERNEST MARIO, PH.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF AN AMENDMENT TO THE COMPANY’S 2008 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

4.

 

APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

5.

 

RATIFICATION OF AN AMENDMENT TO THE COMPANY’S BY-LAWS.

 

Management

 

For

 

For

 

6.

 

STOCKHOLDER PROPOSAL TO REQUEST A BY-LAW PROVISION GRANTING STOCKHOLDERS THE RIGHT TO CALL SPECIAL MEETINGS, DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT.

 

Shareholder

 

Against

 

For

 

7.

 

STOCKHOLDER PROPOSAL TO REQUEST A PROXY ACCESS BY-LAW PROVISION, DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT.

 

Shareholder

 

Against

 

For

 

 

CELLECTIS S.A.

 

Security

 

15117K103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CLLS

 

 

 

Meeting Date

 

17-May-2016

Record Date

 

18-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

APPROVAL OF THE ANNUAL FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015

 

Management

 

For

 

For

 

2.

 

APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015

 

Management

 

For

 

For

 

3.

 

ALLOCATION OF INCOME FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015

 

Management

 

For

 

For

 

4.

 

APPROVAL OF THE AGREEMENTS REFERRED TO IN ARTICLES L. 225-38 AND FOLLOWING OF THE FRENCH COMMERCIAL CODE

 

Management

 

For

 

For

 

5.

 

REAPPOINTMENT OF MR. MATHIEU SIMON TO THE BOARD OF DIRECTORS

 

Management

 

For

 

For

 

6.

 

AUTHORIZATION TO BE GIVEN TO THE BOARD OF DIRECTORS TO BUY BACK COMPANY SHARES

 

Management

 

For

 

For

 

7.

 

AUTHORIZATION TO BE GIVEN TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF REDUCING THE SHARE CAPITAL THROUGH THE CANCELLATION OF SHARES IN THE CONTEXT OF THE AUTHORIZATION TO BUY BACK ITS OWN SHARES

 

Management

 

For

 

For

 

8.

 

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF INCREASING THE SHARE CAPITAL BY ISSUING ORDINARY SHARES AND/OR ANY SECURITIES GIVING ACCESS IMMEDIATELY OR IN THE FUTURE TO THE SHARE CAPITAL AND/OR GIVING ENTITLEMENT TO THE ALLOTMENT OF DEBT SECURITIES, WITH A WAIVER OF THE PREFERENTIAL SUBSCRIPTION RIGHTS, IN FAVOR OF A CATEGORY OF PERSONS MEETING SPECIFIED CHARACTERISTICS

 

Management

 

For

 

For

 

9.

 

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF INCREASING THE SHARE CAPITAL THROUGH THE ISSUANCE OF ORDINARY SHARES OR OF ANY SECURITIES WITH A WAIVER OF THE PREFERENTIAL SUBSCRIPTION RIGHTS, IN FAVOR OF A CATEGORY OF PERSONS ENSURING THE UNDERWRITING OF THE COMPANY’S EQUITY SECURITIES THAT MAY ARISE AS PART OF A LINE OF EQUITY FINANCING

 

Management

 

For

 

For

 

10.

 

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF INCREASING THE SHARE CAPITAL IMMEDIATELY OR IN THE FUTURE BY ISSUING ORDINARY SHARES OR ANY SECURITIES GIVING ACCESS IMMEDIATELY OR IN THE FUTURE TO THE SHARE CAPITAL OR GIVING ENTITLEMENT TO THE ALLOTMENT OF DEBT SECURITIES, WHILE MAINTAINING THE PREFERENTIAL SUBSCRIPTION RIGHTS

 

Management

 

For

 

For

 

11.

 

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF INCREASING THE SHARE CAPITAL IMMEDIATELY OR IN THE FUTURE THROUGH THE ISSUANCE OF ORDINARY SHARES OR OF ANY SECURITIES GIVING ACCESS IMMEDIATELY OR IN THE FUTURE TO THE SHARE CAPITAL OR GIVING ENTITLEMENT TO THE ALLOTMENT OF DEBT SECURITIES, WITH A WAIVER OF THE PREFERENTIAL SUBSCRIPTION RIGHTS AND PUBLIC OFFERING

 

Management

 

For

 

For

 

12.

 

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF INCREASING THE SHARE CAPITAL THROUGH THE ISSUANCE OF ORDINARY SHARES AND/OR OF ANY SECURITIES GIVING ACCESS IMMEDIATELY OR IN THE FUTURE TO THE SHARE CAPITAL OR GIVING ENTITLEMENT TO THE ALLOTMENT OF DEBT SECURITIES, WITH A WAIVER OF THE PREFERENTIAL SUBSCRIPTION RIGHTS OF THE SHAREHOLDERS, THROUGH AN OFFER TO QUALIFIED INVESTORS OR A LIMITED CIRCLE OF INVESTORS WITHIN THE MEANING OF PARAGRAPH II OF ARTICLE L. 411-2 OF THE FRENCH MONETARY AND FINANCIAL CODE

 

Management

 

For

 

For

 

13.

 

DELEGATION GRANTED TO THE BOARD OF DIRECTORS TO INCREASE THE NUMBER OF SECURITIES TO BE ISSUED IN CASE OF SHARE CAPITAL INCREASE WITH OR WITHOUT PREFERENTIAL SUBSCRIPTION RIGHTS

 

Management

 

For

 

For

 

14.

 

OVERALL LIMITATIONS TO THE AMOUNT OF ISSUANCES MADE UNDER THE EIGHTH RESOLUTION, THE NINTH RESOLUTION, THE TENTH RESOLUTION, THE ELEVENTH RESOLUTION, THE TWELFTH RESOLUTION AND THE THIRTEENTH RESOLUTION ABOVE

 

Management

 

For

 

For

 

15.

 

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF INCREASING THE SHARE CAPITAL BY INCORPORATION OF PREMIUMS, RESERVES, PROFITS OR OTHERS

 

Management

 

For

 

For

 

16.

 

AUTHORIZATION TO BE GIVEN TO THE BOARD OF DIRECTORS TO GRANT OPTIONS TO SUBSCRIBE OR PURCHASE COMPANY’S SHARES

 

Management

 

For

 

For

 

17.

 

AUTHORIZATION TO BE GIVEN TO THE BOARD OF DIRECTORS FOR THE ALLOCATION OF FREE SHARES EXISTING AND/OR TO BE ISSUED IN THE FUTURE

 

Management

 

For

 

For

 

18.

 

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS TO ISSUE AND GRANT SHARE WARRANTS TO (I) MEMBERS AND NON- VOTING MEMBERS (CENSEURS) OF THE COMPANY’S BOARD OF DIRECTORS IN OFFICE ON THE DATE THE WARRANTS ARE GRANTED WHO ARE NOT EMPLOYEES OR SENIOR EXECUTIVES OF THE COMPANY OR ONE OF ITS SUBSIDIARIES OR (II) PERSONS WHO HAVE ENTERED INTO A SERVICES OR CONSULTANTS CONTRACT WITH THE COMPANY OR WITH ONE OF ITS SUBSIDIARIES OR (III) MEMBERS OF ANY COMMITTEE WHICH THE BOARD OF DIRECTORS ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

19.

 

DELEGATION OF AUTHORITY TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF ISSUING WARRANTS TO SUBSCRIBE TO AND/OR ACQUIRE REDEEMABLE SHARES (BSAAR) OR SHARE SUBSCRIPTION WARRANTS - WITH A WAIVER OF THE PREFERENTIAL SUBSCRIPTION RIGHTS IN FAVOR OF THE FOLLOWING CATEGORY OF BENEFICIARIES: EMPLOYEES AND CORPORATE OFFICERS OF THE COMPANY AND ITS SUBSIDIARIES

 

Management

 

For

 

For

 

20.

 

AUTHORIZATION FOR THE BOARD OF DIRECTORS TO FREELY ALLOCATE PREFERRED SHARES OF THE COMPANY TO THE EMPLOYEES AND/OR THE EXECUTIVE OFFICERS OF THE COMPANY AND ITS SUBSIDIARIES ENTAILING THE WAIVER BY THE SHAREHOLDERS OF THEIR PREFERENTIAL SUBSCRIPTION RIGHTS

 

Management

 

For

 

For

 

21.

 

OVERALL LIMITATIONS TO THE AMOUNT OF ISSUES MADE UNDER THE SIXTEENTH RESOLUTION, THE SEVENTEENTH RESOLUTION, THE EIGHTEENTH RESOLUTION, THE NINETEENTH RESOLUTION AND THE TWENTIETH RESOLUTION ABOVE

 

Management

 

For

 

For

 

22.

 

DELEGATION TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF AN INCREASE IN THE SHARE CAPITAL WHOSE SUBSCRIPTION WOULD BE RESERVED TO MEMBERS OF A COMPANY SAVINGS PLAN ESTABLISHED PURSUANT TO ARTICLES L. 3332-18 AND FOLLOWING OF THE FRENCH LABOR CODE

 

Shareholder

 

Against

 

For

 

 


 

CEPHEID

 

Security

 

15670R107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CPHD

 

 

 

Meeting Date

 

26-Apr-2016

Record Date

 

04-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

TO ELECT CLASS II DIRECTOR TO SERVE FOR A THREE-YEAR TERM: THOMAS L. GUTSHALL

 

Management

 

For

 

For

 

1B.

 

TO ELECT CLASS II DIRECTOR TO SERVE FOR A THREE-YEAR TERM: CRISTINA H. KEPNER

 

Management

 

For

 

For

 

1C.

 

TO ELECT CLASS II DIRECTOR TO SERVE FOR A THREE-YEAR TERM: DAVID H. PERSING, M.D., PH.D.

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CEPHEID FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

TO APPROVE A NON-BINDING ADVISORY RESOLUTION ON CEPHEID’S EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 

CHIMERIX INC.

 

Security

 

16934W106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CMRX

 

 

 

Meeting Date

 

24-Jun-2016

Record Date

 

27-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1                 C L GILLISS PHD RN FAAN

 

 

 

For

 

For

 

 

 

2                 C. PATRICK MACHADO

 

 

 

For

 

For

 

 

 

3                 ERNEST MARIO, PH.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY NON-BINDING VOTE, THE COMPENSATION OF CHIMERIX, INC.’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

Against

 

Against

 

4.

 

TO RECOMMEND, BY NON-BINDING VOTE, THE FREQUENCY OF EXECUTIVE COMPENSATION VOTES.

 

Management

 

1 Year

 

For

 

 


 

CIDARA THERAPEUTICS, INC.

 

Security

 

171757107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CDTX

 

 

 

Meeting Date

 

22-Jun-2016

Record Date

 

25-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1                 SCOTT ROCKLAGE, PH.D.

 

 

 

For

 

For

 

 

 

2                 JEFFREY STEIN, PH.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2016

 

Management

 

For

 

For

 

 

CYTOMX THERAPEUTICS, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

01-Oct-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF REVERSE STOCK SPLIT; AUTHORIZATION OF AMENDMENT AND RESTATEMENT OF CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

2

 

WRITTEN CONSENT: COUNTERPARTS

 

Management

 

For

 

For

 

 

CYTOMX THERAPEUTICS, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

06-Oct-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

2

 

ADOPTION OF AMENDED AND RESTATED BYLAWS

 

Management

 

For

 

For

 

3

 

FURTHER GRANT OF AUTHORITY

 

Management

 

For

 

For

 

 

CYTOMX THERAPEUTICS, INC.

 

Security

 

23284F105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CTMX

 

 

 

Meeting Date

 

10-Jun-2016

Record Date

 

12-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: SEAN A. MCCARTHY

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

TO ADOPT AND APPROVE THE CYTOMX THERAPEUTICS, INC. ANNUAL INCENTIVE PLAN.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE PERFORMANCE MEASURES INCLUDED IN THE CYTOMX THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

DEPOMED, INC.

 

Security

 

249908104

 

 

 

Meeting Type

 

Contested-Consent

Ticker Symbol

 

DEPO

 

 

 

Meeting Date

 

20-Nov-2015

Record Date

 

29-Oct-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

01

 

THIS PROPOSAL REFERS TO THE WHITE CARD. THIS VIF, WHEN PROPERLY EXECUTED, WILL GRANT HORIZON A PROXY TO REQUEST THE REMOVAL AND BYLAW AMENDMENTS SPECIAL MEETING BUT WILL NOT GRANT HORIZON AUTHORITY TO VOTE ON ANY MATTER PRESENTED AT THE REMOVAL AND BYLAW AMENDMENTS SPECIAL MEETING. A PROPERLY EXECUTED VIF FOR WHICH NO INSTRUCTION IS GIVEN WILL GRANT HORIZON A PROXY TO REQUEST THE REMOVAL AND BYLAW AMENDMENTS SPECIAL MEETING.

 

Management

 

Against

 

Against

 

02

 

THIS PROPOSAL REFERS TO THE BLUE CARD. THIS VIF, WHEN PROPERLY EXECUTED, WILL GRANT HORIZON A PROXY TO REQUEST THE ELECTION SPECIAL MEETING BUT WILL NOT GRANT HORIZON AUTHORITY TO VOTE ON ANY MATTER PRESENTED AT THE ELECTION SPECIAL MEETING. A PROPERLY EXECUTED VIF FOR WHICH NO INSTRUCTION IS GIVEN WILL GRANT HORIZON A PROXY TO REQUEST THE ELECTION SPECIAL MEETING.

 

Management

 

Against

 

Against

 

 


 

DEPOMED, INC.

 

Security

 

249908104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

DEPO

 

 

 

Meeting Date

 

18-May-2016

Record Date

 

31-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: PETER D. STAPLE

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: KAREN A. DAWES

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: LOUIS J. LAVIGNE, JR.

 

Management

 

For

 

For

 

1.4

 

ELECTION OF DIRECTOR: SAMUEL R. SAKS, M.D.

 

Management

 

For

 

For

 

1.5

 

ELECTION OF DIRECTOR: JAMES A. SCHOENECK

 

Management

 

For

 

For

 

1.6

 

ELECTION OF DIRECTOR: DAVID B. ZENOFF, D.B.A.

 

Management

 

For

 

For

 

2.

 

TO APPROVE AN INCREASE IN THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE COMPANY’S AMENDED AND RESTATED 2014 OMNIBUS INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN INCREASE IN THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE COMPANY’S AMENDED AND RESTATED 2004 EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

5.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

DYNAVAX TECHNOLOGIES CORPORATION

 

Security

 

268158201

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

DVAX

 

 

 

Meeting Date

 

31-May-2016

Record Date

 

06-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1                 DENNIS A. CARSON, M.D.

 

 

 

For

 

For

 

 

 

2                 EDDIE GRAY

 

 

 

For

 

For

 

 

 

3                 LAURA BREGE

 

 

 

For

 

For

 

2.

 

TO AMEND AND RESTATE THE DYNAVAX TECHNOLOGIES CORPORATION 2011 EQUITY INCENTIVE PLAN TO, AMONG OTHER THINGS, INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THAT PLAN BY 3,200,000, AND TO APPROVE THE AWARD LIMITS AND OTHER TERMS APPLICABLE TO AWARDS INTENDED TO QUALIFY AS “PERFORMANCE-BASED COMPENSATION” FOR PURPOSES OF SECTION 162(M) OF THE INTERNAL REVENUE CODE.

 

Management

 

For

 

For

 

3.

 

TO AMEND AND RESTATE THE DYNAVAX TECHNOLOGIES CORPORATION 2014 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THAT PLAN BY 200,000.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

5.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

ENDO INTERNATIONAL PLC

 

Security

 

G30401106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ENDP

 

 

 

Meeting Date

 

09-Jun-2016

Record Date

 

14-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: ROGER H. KIMMEL

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: RAJIV DE SILVA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: SHANE M. COOKE

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: ARTHUR J. HIGGINS

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: NANCY J. HUTSON, PH.D.

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MICHAEL HYATT

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: WILLIAM P. MONTAGUE

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: JILL D. SMITH

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: WILLIAM F. SPENGLER

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE YEAR ENDING DECEMBER 31, 2016 AND TO AUTHORIZE THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS TO DETERMINE THE AUDITORS’ REMUNERATION.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE AMENDMENT OF THE COMPANY’S MEMORANDUM OF ASSOCIATION.

 

Management

 

For

 

For

 

5.

 

TO APPROVE THE AMENDMENT OF THE COMPANY’S ARTICLES OF ASSOCIATION.

 

Management

 

For

 

For

 

6.

 

TO APPROVE THE AMENDMENT OF THE COMPANY’S 2015 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: DOUGLAS S. INGRAM

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: TODD SISITSKY

 

Management

 

For

 

For

 

 


 

EPIZYME INC.

 

Security

 

29428V104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

EPZM

 

 

 

Meeting Date

 

19-May-2016

Record Date

 

01-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1                 DAVID M. MOTT

 

 

 

For

 

For

 

 

 

2                 RICHARD F. POPS

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS EPIZYME’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

EXELIXIS, INC.

 

Security

 

30161Q104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

EXEL

 

 

 

Meeting Date

 

25-May-2016

Record Date

 

31-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF CLASS II DIRECTOR: CARL B. FELDBAUM, ESQ.

 

Management

 

For

 

For

 

1.2

 

ELECTION OF CLASS II DIRECTOR: ALAN M. GARBER, M.D., PH.D.

 

Management

 

For

 

For

 

1.3

 

ELECTION OF CLASS II DIRECTOR: VINCENT T. MARCHESI, M.D., PH.D.

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS EXELIXIS’ INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 30, 2016.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT AND RESTATEMENT OF THE EXELIXIS, INC. 2000 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 2000 EMPLOYEE STOCK PURCHASE PLAN BY 5,000,000 SHARES AND MAKE CERTAIN OTHER CHANGES AS DESCRIBED IN PROPOSAL 3 OF THE ACCOMPANYING PROXY STATEMENT.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF EXELIXIS’ NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT.

 

Management

 

For

 

For

 

 

FLEX PHARMA INC

 

Security

 

33938A105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

FLKS

 

 

 

Meeting Date

 

07-Jun-2016

Record Date

 

11-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1                 MARC KOZIN

 

 

 

For

 

For

 

 

 

2                 RODERICK MACKINNON

 

 

 

For

 

For

 

 

 

3                 MICHELLE STACY

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 


 

FOAMIX PHARMACEUTICALS LTD

 

Security

 

M46135105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

FOMX

 

 

 

Meeting Date

 

18-Apr-2016

Record Date

 

15-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

APPOINT KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2016, AND AUTHORIZE THE BOARD TO DETERMINE THE COMPENSATION OF THE AUDITORS.

 

Management

 

For

 

For

 

2.

 

APPROVE THE FOLLOWING RESOLUTIONS WITH REGARD TO THE COMPENSATION OF DR. DOV TAMARKIN, OUR CHIEF EXECUTIVE OFFICER: (A) GRANT DR. TAMARKIN A CASH BONUS OF $181,837 FOR THE YEAR ENDED DECEMBER 31, 2015, BASED ON THE ACHIEVEMENT OF THE GOALS SET AND EVALUATED BY OUR COMPENSATION COMMITTEE; (B) INCREASE DR. TAMARKIN’S ANNUAL BASE SALARY TO $385,000, EFFECTIVE NOVEMBER 1, 2015; AND (C) AWARD DR. TAMARKIN 100,000 OPTIONS UNDER THE COMPANY’S 2015 ISRAELI SHARE INCENTIVE PLAN.

 

Management

 

For

 

For

 

2B.

 

IF YOU DO NOT HAVE A PERSONAL INTEREST MARK FOR= YES. IF YOU DO NOT MARK FOR=YES, YOUR VOTE FOR PROP 2 WILL NOT BE VALID

 

Management

 

For

 

 

 

3.

 

APPROVE DR. TAMARKIN’S (A) ANNUAL CASH BONUS FOR THE YEAR ENDING DECEMBER 31, 2016, UP TO A MAXIMUM AMOUNT OF $231,000, SUBJECT TO ACHIEVING THE KEY PERFORMANCE INDICATORS DETAILED IN THE PROXY STATEMENT, AND (B) AN ADDITIONAL SPECIAL CASH BONUS, FOR THE YEAR ENDING DECEMBER 31, 2016, IN AN AMOUNT OF UP TO $231,000, UPON UNIQUE SUCCESS BEYOND EXPECTATIONS IN ACHIEVING CERTAIN GOALS DETAILED IN THE PROXY STATEMENT, IN EACH CASE, SUBJECT TO THE RECOMMENDATIONS OF THE COMPANY’S COMPENSATION COMMITTEE AND THE BOARD APPROVAL.

 

Management

 

Against

 

Against

 

3B.

 

IF YOU DO NOT HAVE A PERSONAL INTEREST MARK FOR= YES. IF YOU DO NOT MARK FOR=YES, YOUR VOTE FOR PROP 3 WILL NOT BE VALID

 

Management

 

For

 

 

 

4.

 

APPROVE THE FOLLOWING RESOLUTIONS WITH REGARD TO THE COMPENSATION OF MEIR EINI, CHAIRMAN OF THE BOARD AND CHIEF INNOVATION OFFICER: (A) GRANT MR. EINI A CASH BONUS OF $200,777 FOR THE YEAR ENDED DECEMBER 31, 2015, BASED ON THE ACHIEVEMENT OF THE GOALS SET AND EVALUATED BY OUR COMPENSATION COMMITTEE; (B) INCREASE MR. EINI’S ANNUAL BASE SALARY TO $369,000, EFFECTIVE NOVEMBER 1, 2015; AND (C) AWARD MR. EINI 55,000 OPTIONS UNDER THE COMPANY’S 2015 ISRAELI SHARE INCENTIVE PLAN.

 

Management

 

Against

 

Against

 

5.

 

APPROVE MR. EINI’S (A) ANNUAL CASH BONUS FOR THE YEAR ENDING DECEMBER 31, 2016, UP TO A MAXIMUM AMOUNT OF $184,500, SUBJECT TO ACHIEVING THE KEY PERFORMANCE INDICATORS DETAILED IN THIS PROXY STATEMENT, AND (B) AN ADDITIONAL SPECIAL CASH BONUS, FOR THE YEAR ENDING DECEMBER 31, 2016, IN AN AMOUNT OF UP TO $184,500, UPON UNIQUE SUCCESS BEYOND EXPECTATIONS IN ACHIEVING CERTAIN GOALS DETAILED IN THIS PROXY STATEMENT, IN EACH CASE, SUBJECT TO THE RECOMMENDATIONS OF THE COMPANY’S COMPENSATION COMMITTEE AND THE BOARD APPROVAL.

 

Management

 

Against

 

Against

 

 

GALAPAGOS N V

 

Security

 

36315X101

 

 

 

Meeting Type

 

Special

Ticker Symbol

 

GLPG

 

 

 

Meeting Date

 

22-Dec-2015

Record Date

 

8-Dec-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

TO CONFIRM THE APPOINTMENT OF DR. CHRISTINE MUMMERY AS DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE PROPOSAL TO OFFER ADDITIONAL WARRANTS.

 

Management

 

For

 

For

 

 


 

GALAPAGOS N V

 

Security

 

36315X101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

GLPG

 

 

 

Meeting Date

 

26-Apr-2016

Record Date

 

7-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

2.

 

COMMUNICATION AND APPROVAL OF THE NON-CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2015 AND THE ALLOCATION OF THE ANNUAL RESULT AS PROPOSED BY THE BOARD OF DIRECTORS.

 

Management

 

For

 

For

 

5.

 

COMMUNICATION AND APPROVAL OF THE REMUNERATION REPORT.

 

Management

 

For

 

For

 

6.

 

RELEASE FROM LIABILITY TO BE GRANTED TO THE DIRECTORS AND THE STATUTORY AUDITOR FOR THE PERFORMANCE OF THEIR DUTIES IN THE COURSE OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2015.

 

Management

 

For

 

For

 

7.

 

REMUNERATION OF DIRECTORS.

 

Management

 

For

 

For

 

8.

 

OFFER OF WARRANTS.

 

Management

 

For

 

For

 

9.

 

APPLICATION OF ARTICLE 556 OF THE BELGIAN COMPANIES CODE.

 

Management

 

For

 

For

 

E2.

 

AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL BY UP TO 20% OF THE SHARE CAPITAL.

 

Management

 

For

 

For

 

E3.

 

AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL BY UP TO 50% OF THE SHARE CAPITAL, IN SPECIFIC CIRCUMSTANCES.

 

Management

 

For

 

For

 

E4.

 

AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL BY UP TO 100% OF THE SHARE CAPITAL, IN SPECIFIC CIRCUMSTANCES WITH UNANIMOUS CONSENT.

 

Management

 

For

 

For

 

E5.

 

AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL AFTER NOTIFICATION OF A PUBLIC TAKEOVER BID.

 

Management

 

For

 

For

 

 

GALAPAGOS NV, MECHELEN

 

Security

 

B44170106

 

 

 

Meeting Type

 

Special General Meeting

Ticker Symbol

 

GLPG

 

 

 

Meeting Date

 

22-Dec-2015

Record Date

 

8-Dec-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

CMMT

 

IMPORTANT MARKET PROCESSING REQUIREMENT: A BENEFICIAL OWNER SIGNED POWER OF ATTORNEY (POA) MAY BE REQUIRED IN ORDER TO LODGE AND EXECUTE YOUR VOTING INSTRUCTIONS IN THIS MARKET. ABSENCE OF A POA, MAY CAUSE YOUR INSTRUCTIONS TO BE REJECTED. IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE

 

Non-Voting

 

 

 

 

 

CMMT

 

MARKET RULES REQUIRE DISCLOSURE OF BENEFICIAL OWNER INFORMATION FOR ALL VOTED ACCOUNTS. IF AN ACCOUNT HAS MULTIPLE BENEFICIAL OWNERS, YOU WILL NEED TO PROVIDE THE BREAKDOWN OF EACH BENEFICIAL OWNER NAME, ADDRESS AND SHARE-POSITION TO YOUR CLIENT SERVICE REPRESENTATIVE. THIS INFORMATION IS REQUIRED IN ORDER FOR YOUR VOTE TO BE LODGED

 

Non-Voting

 

 

 

 

 

1

 

CONFIRMATION OF APPOINTMENT OF INDEPENDENT DIRECTOR: THE SHAREHOLDERS’ MEETING RESOLVES TO CONFIRM THE APPOINTMENT OF DR. CHRISTINE MUMMERY (RESIDING IN BILTHOVEN, THE NETHERLANDS) AS A DIRECTOR OF THE COMPANY, MADE BY THE BOARD AS FROM 30 SEPTEMBER 2015 TO FILL A VACANCY, AND TO APPOINT HER AS A DIRECTOR OF THE COMPANY FOR A PERIOD OF FOUR YEARS ENDING IMMEDIATELY AFTER THE SHAREHOLDERS’ MEETING IN 2019 WHICH HAS THE APPROVAL OF THE ANNUAL ACCOUNTS ON ITS AGENDA. UPON THE PROPOSAL OF THE BOARD AND IN ACCORDANCE WITH THE ADVICE OF THE COMPANY’S NOMINATION AND REMUNERATION COMMITTEE, THE SHAREHOLDERS’ MEETING FURTHER RESOLVES TO APPOINT DR. MUMMERY AS AN INDEPENDENT DIRECTOR AS SHE MEETS THE CRITERIA OF INDEPENDENCE SET FORTH IN ARTICLE 526TER OF THE BELGIAN COMPANIES CODE AND DR. MUMMERY EXPRESSLY STATED, AND AS FAR AS THE BOARD IS AWARE, SHE DOES NOT HAVE ANY RELATIONSHIP WITH ANY COMPANY THAT WOULD COMPROMISE HER INDEPENDENCE. THE SHAREHOLDERS’ MEETING ACKNOWLEDGES THAT THE BOARD MAY DETERMINE THE REMUNERATION TO BE GRANTED TO DR. MUMMERY FOR THE EXERCISE OF HER MANDATE AS A DIRECTOR OF THE COMPANY WITHIN THE LIMITS OF THE POWER OF ATTORNEY UNANIMOUSLY APPROVED BY THE SHAREHOLDERS’ MEETING ON 28 APRIL 2015 (EIGHTH AGENDA ITEM - REMUNERATION OF DIRECTORS )

 

Management

 

For

 

For

 

2

 

OFFER OF WARRANTS: THE SHAREHOLDERS’ MEETING RESOLVES TO APPROVE THE PROPOSAL OF THE COMPANY’S NOMINATION AND REMUNERATION COMMITTEE TO OFFER ADDITIONAL WARRANTS TO THE COMPANY’S DIRECTORS IN LIGHT OF AN INDEPENDENT BENCHMARKING EXERCISE AND RECOMMENDATION BY AN EXTERNAL ADVISOR, FOLLOWING THE GROWTH OF THE COMPANY AND THE RECENT US LISTING OF THE COMPANY ON NASDAQ AND CONSEQUENTLY (I) RESOLVES TO OFFER 100,000 WARRANTS TO MR. ONNO VAN DE STOLPE, 15,000 WARRANTS TO DR. RAJ PAREKH, AND 7,500 WARRANTS TO EACH OF DR. WERNER CAUTREELS, DR. HARROLD VAN BARLINGEN, MR. HOWARD ROWE, MS. KATRINE BOSLEY AND DR. CHRISTINE MUMMERY, UNDER WARRANT PLANS TO BE CREATED BY THE BOARD OF DIRECTORS FOR THE BENEFIT OF DIRECTORS, EMPLOYEES AND INDEPENDENT CONSULTANTS OF GALAPAGOS AND ITS AFFILIATES WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL (JOINTLY “WARRANT PLAN 2015 (B)”), THE KEY CONDITIONS OF WHICH WILL BE IN LINE WITH PREVIOUS WARRANT PLANS OF THE COMPANY, (II) EMPOWERS THE MANAGING DIRECTOR, AS WELL AS ANY OTHER DIRECTOR AS REGARDS THE OFFER TO THE MANAGING DIRECTOR, TO IMPLEMENT THIS OFFER, AND (III) TO THE EXTENT REQUIRED, APPROVES THE OFFER OF WARRANTS TO MEMBERS OF GALAPAGOS’ EXECUTIVE COMMITTEE UNDER WARRANT PLAN 2015 ... (DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

 


 

GALAPAGOS NV, MECHELEN

 

Security

 

B44170106

 

 

 

Meeting Type

 

MIX

Ticker Symbol

 

GLPG

 

 

 

Meeting Date

 

26-Apr-2016

Record Date

 

12-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

CMMT

 

MARKET RULES REQUIRE DISCLOSURE OF BENEFICIAL OWNER INFORMATION FOR ALL VOTED ACCOUNTS. IF AN ACCOUNT HAS MULTIPLE BENEFICIAL OWNERS, YOU WILL NEED TO-PROVIDE THE BREAKDOWN OF EACH BENEFICIAL OWNER NAME, ADDRESS AND SHARE-POSITION TO YOUR CLIENT SERVICE REPRESENTATIVE. THIS INFORMATION IS REQUIRED IN ORDER FOR YOUR VOTE TO BE LODGED

 

Non-Voting

 

 

 

 

 

CMMT

 

IMPORTANT MARKET PROCESSING REQUIREMENT: A BENEFICIAL OWNER SIGNED POWER OF ATTORNEY (POA) MAY BE REQUIRED IN ORDER TO LODGE AND EXECUTE YOUR VOTING INSTRUCTIONS IN THIS MARKET. ABSENCE OF A POA, MAY CAUSE YOUR INSTRUCTIONS TO BE REJECTED. IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE

 

Non-Voting

 

 

 

 

 

A.1

 

COMMUNICATION AND DISCUSSION OF THE ANNUAL REPORT OF THE BOARD OF DIRECTORS RELATING TO THE NON-CONSOLIDATED AND CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2015, AND OF THE REPORT OF THE STATUTORY AUDITOR RELATING TO THE NON-CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2015

 

Non-Voting

 

 

 

 

 

A.2

 

THE SHAREHOLDERS’ MEETING RESOLVES TO APPROVE THE NON-CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2015, AS WELL AS THE ALLOCATION OF THE ANNUAL RESULT AS PROPOSED BY THE BOARD OF DIRECTORS

 

Management

 

For

 

For

 

A.3

 

COMMUNICATION AND DISCUSSION OF THE REPORT OF THE STATUTORY AUDITOR RELATING TO THE CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR-ENDED ON 31 DECEMBER 2015

 

Non-Voting

 

 

 

 

 

A.4

 

COMMUNICATION AND DISCUSSION OF THE CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2015

 

Non-Voting

 

 

 

 

 

A.5

 

THE SHAREHOLDERS’ MEETING RESOLVES TO APPROVE THE REMUNERATION REPORT

 

Management

 

For

 

For

 

A.6

 

THE SHAREHOLDERS’ MEETING RESOLVES, BY SEPARATE VOTE, TO RELEASE EACH DIRECTOR AND THE STATUTORY AUDITOR FROM ANY LIABILITY ARISING FROM THE PERFORMANCE OF THEIR DUTIES DURING THE LAST FINANCIAL YEAR

 

Management

 

For

 

For

 

A.7

 

UPON RECOMMENDATION OF THE COMPANY’S NOMINATION AND REMUNERATION COMMITTEE, THE SHAREHOLDERS’ MEETING RESOLVES THAT (A) THE COMPENSATION (EXCLUDING EXPENSES) OF THE NON-EXECUTIVE DIRECTORS FOR THE EXERCISE OF THEIR MANDATE DURING THE FINANCIAL YEAR ENDING 31 DECEMBER 2016 IS ESTABLISHED AS FOLLOWS: (I) CHAIRMAN OF THE BOARD: EUR 80,000; (II) OTHER NON-EXECUTIVE BOARD MEMBERS: EUR 40,000 EACH; (III) ANNUAL ADDITIONAL COMPENSATION FOR MEMBERSHIP OF A BOARD COMMITTEE: EUR 5,000; (IV) ANNUAL ADDITIONAL COMPENSATION FOR THE CHAIRMANSHIP OF A BOARD COMMITTEE: EUR 10,000; AND (B) POWER OF ATTORNEY IS GRANTED TO THE BOARD OF DIRECTORS TO DETERMINE THE TOTAL REMUNERATION PACKAGE OF THE MANAGING DIRECTOR (CEO) FOR HIS MANAGEMENT FUNCTION IN THE COMPANY, IT BEING UNDERSTOOD THAT THIS REMUNERATION SHALL INCLUDE A COMPENSATION FOR THE PERFORMANCE OF HIS MANDATE AS A DIRECTOR OF THE COMPANY

 

Management

 

For

 

For

 

A.8

 

UPON RECOMMENDATION OF THE COMPANY’S NOMINATION AND REMUNERATION COMMITTEE, THE SHAREHOLDERS’ MEETING (I) RESOLVES TO OFFER 100,000 WARRANTS TO MR. ONNO VAN DE STOLPE, 15,000 WARRANTS TO DR. RAJ PAREKH, AND 7,500 WARRANTS TO EACH OF DR. WERNER CAUTREELS, DR. HARROLD VAN BARLINGEN, MR. HOWARD ROWE, MS. KATRINE BOSLEY AND DR. CHRISTINE MUMMERY, UNDER WARRANT PLANS TO BE CREATED BY THE BOARD OF DIRECTORS FOR THE BENEFIT OF DIRECTORS, EMPLOYEES AND INDEPENDENT CONSULTANTS OF GALAPAGOS AND ITS AFFILIATES WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL (JOINTLY “WARRANT PLAN 2016”), THE KEY CONDITIONS OF WHICH WILL BE IN LINE WITH PREVIOUS WARRANT PLANS OF THE COMPANY, (II) EMPOWERS THE MANAGING DIRECTOR, AS WELL AS ANY OTHER DIRECTOR AS REGARDS THE OFFER TO THE MANAGING DIRECTOR, TO IMPLEMENT THIS OFFER, AND (III) TO THE EXTENT REQUIRED, APPROVES THE OFFER OF WARRANTS TO MEMBERS OF GALAPAGOS’ EXECUTIVE COMMITTEE UNDER WARRANT PLAN 2016 IN ACCORDANCE WITH GALAPAGOS’ REMUNERATION POLICY AND PRACTICES... (DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

A.9

 

IN ACCORDANCE WITH ARTICLE 556 OF THE BELGIAN COMPANIES CODE, THE SHAREHOLDERS’ MEETING RESOLVES TO APPROVE, AND TO THE EXTENT REQUIRED, RATIFY ALL OF THE PROVISIONS GRANTING RIGHTS TO THIRD PARTIES WHICH COULD AFFECT THE ASSETS OF THE COMPANY, OR COULD IMPOSE AN OBLIGATION ON THE COMPANY, WHERE THE EXERCISE OF THOSE RIGHTS IS DEPENDENT ON A PUBLIC TAKEOVER BID ON THE SHARES OF THE COMPANY OR A CHANGE OF CONTROL IN RESPECT OF THE COMPANY, AS INCLUDED IN: (A) THE LICENSE AND COLLABORATION AGREEMENT BETWEEN GALAPAGOS NV AND GILEAD BIOPHARMACEUTICS IRELAND UNLIMITED COMPANY DATED 16 DECEMBER 2015 (THE “LICENSE AND COLLABORATION AGREEMENT”) INCLUDING, BUT NOT LIMITED TO, CLAUSE 15.6 (ASSIGNMENT; INDUSTRY TRANSACTION; ACQUIRED PROGRAMS) OF THE LICENSE AND COLLABORATION AGREEMENT, ENTITLING THE COUNTERPARTY (I) IN THE EVENT OF AN INDUSTRY TRANSACTION INVOLVING THE COMPANY, AS A RESULT OF WHICH A DRUG COMPANY OF A CERTAIN MINIMUM SIZE ACQUIRES CONTROL OVER THE COMPANY, TO TERMINATE THE COMPANY’S CO-PROMOTION RIGHTS, TO DISBAND ALL JOINT COMMITTEES AND UNDERTAKE EXCLUSIVE CONTROL OF THEIR ACTIVITIES; AND (II) IN THE EVENT OF A CHANGE OF CONTROL AS A RESULT OF WHICH THE COMPANY ACQUIRES RIGHTS TO AN ALTERNATIVE PRODUCT THAT WOULD VIOLATE CERTAIN OF COMPANY’S EXCLUSIVITY OBLIGATIONS UNDER THE LICENSE AND COLLABORATION AGREEMENT...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL).

 

Management

 

For

 

For

 

A.10

 

MISCELLANEOUS

 

Non-Voting

 

 

 

 

 

E.1

 

CONSIDERATION AND DISCUSSION OF THE SPECIAL REPORT OF THE BOARD OF DIRECTORS- IN ACCORDANCE WITH ARTICLE 604 OF THE BELGIAN COMPANIES CODE RELATING TO THE RENEWAL OF ITS AUTHORIZATION WITH RESPECT TO, AND THE INCREASE OF, THE AUTHORIZED CAPITAL

 

Non-Voting

 

 

 

 

 

E.2

 

THE SHAREHOLDERS’ MEETING RESOLVES TO DELETE SECTIONS (1) THROUGH (3) OF THE TEMPORARY PROVISIONS OF THE ARTICLES OF ASSOCIATION OF THE COMPANY ENTIRELY AND TO REPLACE THEM WITH THE FOLLOWING TEXT: “AUTHORIZED CAPITAL THE BOARD OF DIRECTORS HAS BEEN GRANTED THE AUTHORITY TO INCREASE THE SHARE CAPITAL OF THE COMPANY, IN ACCORDANCE WITH ARTICLES 603 TO 608 OF THE COMPANIES CODE, IN ONE OR SEVERAL TIMES, TO THE EXTENT SET FORTH HEREAFTER. THIS AUTHORIZATION IS VALID FOR A PERIOD OF FIVE YEARS FROM THE DATE OF PUBLICATION OF THIS AUTHORIZATION IN THE ANNEXES TO THE BELGIAN STATE GAZETTE. WITHOUT PREJUDICE TO MORE RESTRICTIVE RULES SET FORTH BY LAW, THE BOARD OF DIRECTORS CAN INCREASE THE SHARE CAPITAL OF THE COMPANY IN ONE OR SEVERAL TIMES WITH AN AMOUNT OF UP TO EUR [AS SPECIFIED ], I.E. 20% OF THE SHARE CAPITAL AT THE TIME OF THE CONVENING OF THE SHAREHOLDERS’ MEETING GRANTING THIS AUTHORIZATION. IN ACCORDANCE WITH ARTICLE 607 OF THE COMPANIES CODE, THE BOARD OF DIRECTORS CANNOT USE THE AFOREMENTIONED AUTHORIZATION AFTER THE FINANCIAL SERVICES AND MARKETS AUTHORITY (FSMA) HAS NOTIFIED THE COMPANY OF A PUBLIC TAKEOVER BID FOR THE COMPANY’S SHARES THE CAPITAL INCREASES WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL MAY BE ACHIEVED BY THE ISSUANCE OF SHARES (WITH OR WITHOUT VOTING RIGHTS...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

E.3

 

SHAREHOLDERS’ MEETING RESOLVES TO ADD A NEW SECTION TO THE TEMPORARY PROVISIONS OF THE ARTICLES OF ASSOCIATION OF THE COMPANY, AS FOLLOWS: “USE OF AUTHORIZED CAPITAL IN SPECIFIC CIRCUMSTANCES THE BOARD OF DIRECTORS HAS BEEN GRANTED THE AUTHORITY TO INCREASE THE SHARE CAPITAL OF THE COMPANY, IN ACCORDANCE WITH ARTICLES 603 TO 608 OF THE COMPANIES CODE, IN ONE OR SEVERAL TIMES, TO THE EXTENT SET FORTH HEREAFTER. THIS AUTHORIZATION IS VALID FOR A PERIOD OF FIVE YEARS FROM THE DATE OF PUBLICATION OF THIS AUTHORIZATION IN THE ANNEXES TO THE BELGIAN STATE GAZETTE. WITHOUT PREJUDICE TO MORE RESTRICTIVE RULES SET FORTH BY LAW, BUT ALSO WITHOUT PREJUDICE TO ANY OTHER LESS RESTRICTIVE AUTHORIZATIONS GRANTED BY THE EXTRAORDINARY SHAREHOLDERS’ MEETING OF [DATE OF THIS MEETING] 2016, THE BOARD OF DIRECTORS CAN INCREASE THE SHARE CAPITAL OF THE COMPANY IN ONE OR SEVERAL TIMES WITH AN AMOUNT UP TO EUR [ AS SPECIFIED], I.E. 50% OF THE SHARE CAPITAL AT THE TIME OF THE CONVENING OF THE SHAREHOLDERS’ MEETING GRANTING THIS AUTHORIZATION, UPON A RESOLUTION OF THE BOARD OF DIRECTORS THAT ALL INDEPENDENT DIRECTORS (WITHIN THE MEANING OF ARTICLE 526TER OF THE COMPANIES CODE) APPROVED AND RELATING TO ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL).

 

Management

 

For

 

For

 

E.4

 

THE SHAREHOLDERS’ MEETING RESOLVES TO ADD A NEW SECTION TO THE TEMPORARY PROVISIONS OF THE ARTICLES OF ASSOCIATION OF THE COMPANY, AS FOLLOWS: “USE OF AUTHORIZED CAPITAL IN SPECIFIC CIRCUMSTANCES WITH UNANIMOUS CONSENT THE BOARD OF DIRECTORS HAS BEEN GRANTED THE AUTHORITY TO INCREASE THE SHARE CAPITAL OF THE COMPANY, IN ACCORDANCE WITH ARTICLES 603 TO 608 OF THE COMPANIES CODE, IN ONE OR SEVERAL TIMES, TO THE EXTENT SET FORTH HEREAFTER. THIS AUTHORIZATION IS VALID FOR A PERIOD OF FIVE YEARS FROM THE DATE OF PUBLICATION OF THIS AUTHORIZATION IN THE ANNEXES TO THE BELGIAN STATE GAZETTE. WITHOUT PREJUDICE TO MORE RESTRICTIVE RULES SET FORTH BY LAW, BUT ALSO WITHOUT PREJUDICE TO ANY OTHER LESS RESTRICTIVE AUTHORIZATIONS GRANTED BY THE EXTRAORDINARY SHAREHOLDERS’ MEETING OF [DATE OF THIS MEETING] 2016, THE BOARD OF DIRECTORS CAN INCREASE THE SHARE CAPITAL OF THE COMPANY IN ONE OR SEVERAL TIMES WITH AN AMOUNT UP TO EUR [ AS SPECIFIED], I.E. 100% OF THE SHARE CAPITAL AT THE TIME OF THE CONVENING OF THE SHAREHOLDERS’ MEETING GRANTING THIS AUTHORIZATION...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

E.5

 

THE SHAREHOLDERS’ MEETING RESOLVES TO ADD A NEW SECTION TO THE TEMPORARY PROVISIONS OF THE ARTICLES OF ASSOCIATION OF THE COMPANY, AS FOLLOWS: “USE OF THE AUTHORIZATION TO INCREASE THE SHARE CAPITAL AFTER NOTIFICATION OF A PUBLIC TAKEOVER BID, UP TO ONE TENTH OF THE SHARES REPRESENTING THE CAPITAL OF THE COMPANY THAT IS ISSUED PRIOR TO SUCH CAPITAL INCREASE THE BOARD OF DIRECTORS IS EXPRESSLY AUTHORIZED DURING A PERIOD OF THREE YEARS AS OF THE DATE OF THE SHAREHOLDERS’ MEETING WHICH GRANTED THIS AUTHORIZATION, I.E. [DATE OF THIS MEETING] 2016, TO INCREASE THE COMPANY’S SHARE CAPITAL WITHIN THE CONTEXT OF THE AUTHORIZED CAPITAL BY CONTRIBUTIONS IN KIND OR IN CASH WITH RESTRICTION OR CANCELLATION OF THE SHAREHOLDERS’ PREFERENTIAL SUBSCRIPTION RIGHTS, EVEN AFTER THE FINANCIAL SERVICES AND MARKETS AUTHORITY (FSMA) HAS NOTIFIED THE COMPANY OF A PUBLIC TAKEOVER BID FOR THE COMPANY’S SHARES, PROVIDED THAT THE RELEVANT PROVISIONS OF THE COMPANIES CODE (INCLUDING BUT NOT LIMITED TO ARTICLE 607 OF THE COMPANIES CODE) ARE COMPLIED WITH, INCLUDING THAT THE NUMBER OF SHARES ISSUED UNDER SUCH CAPITAL INCREASE DOES NOT EXCEED ONE TENTH OF THE SHARES REPRESENTING THE CAPITAL OF THE COMPANY THAT HAVE BEEN ISSUED PRIOR TO SUCH CAPITAL INCREASE. USE OF THE AFOREMENTIONED AUTHORIZATION REQUIRES A UNANIMOUS RESOLUTION OF THE BOARD OF DIRECTORS AT WHICH ALL DIRECTORS ARE PRESENT OR REPRESENTED. THE AUTHORIZATION REFERRED TO ABOVE MAY BE RENEWED

 

Management

 

For

 

For

 

 


 

GENMARK DIAGNOSTICS, INC.

 

Security

 

372309104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

GNMK

 

 

 

Meeting Date

 

26-May-2016

Record Date

 

30-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LISA M. GILES

 

 

 

For

 

For

 

 

 

2

MICHAEL S. KAGNOFF

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

 

GILEAD SCIENCES, INC.

 

Security

 

375558103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

GILD

 

 

 

Meeting Date

 

11-May-2016

Record Date

 

16-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: JOHN F. COGAN, PH.D.

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: KEVIN E. LOFTON

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: JOHN W. MADIGAN

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: JOHN C. MARTIN, PH.D.

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: JOHN F. MILLIGAN, PH.D.

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: NICHOLAS G. MOORE

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: RICHARD J. WHITLEY, M.D.

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: GAYLE E. WILSON

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: PER WOLD-OLSEN

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

TO APPROVE THE AMENDED AND RESTATED GILEAD SCIENCES, INC. CODE SECTION 162(M) BONUS PLAN.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS PRESENTED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

5.

 

TO VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT THE BOARD TAKE STEPS TO PERMIT STOCKHOLDER ACTION BY WRITTEN CONSENT.

 

Shareholder

 

Against

 

For

 

 


 

HALOZYME THERAPEUTICS, INC.

 

Security

 

40637H109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

HALO

 

 

 

Meeting Date

 

04-May-2016

Record Date

 

10-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JEFFREY W. HENDERSON

 

 

 

For

 

For

 

 

 

2

CONNIE L. MATSUI

 

 

 

For

 

For

 

 

 

3

HELEN I. TORLEY

 

 

 

For

 

For

 

2.

 

TO APPROVE, BY ADVISORY VOTE, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

4.

 

TO APPROVE AMENDMENTS TO THE COMPANY’S 2011 STOCK PLAN.

 

Management

 

For

 

For

 

5.

 

TO APPROVE THE COMPANY’S EXECUTIVE INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

IDEXX LABORATORIES, INC.

 

Security

 

45168D104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

IDXX

 

 

 

Meeting Date

 

04-May-2016

Record Date

 

08-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: JONATHAN W. AYERS

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: BARRY C. JOHNSON, PHD

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: M. ANNE SZOSTAK

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR

 

Management

 

For

 

For

 

3.

 

TO APPROVE A NONBINDING ADVISORY RESOLUTION ON THE COMPANY’S EXECUTIVE COMPENSATION

 

Management

 

For

 

For

 

 

ILLUMINA, INC.

 

Security

 

452327109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ILMN

 

 

 

Meeting Date

 

18-May-2016

Record Date

 

21-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: FRANCES ARNOLD, PH.D.

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: FRANCIS A. DESOUZA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: KARIN EASTHAM, CPA

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JANUARY 1, 2017.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE RATIFICATION OF CERTAIN SUPERMAJORITY VOTING PROVISIONS IN OUR CERTIFICATE OF INCORPORATION AND BYLAWS.

 

Management

 

For

 

For

 

 

ILLUMINOSS MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

05-Nov-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

CONVERTIBLE NOTE FINANCING

 

Management

 

For

 

For

 

2

 

AMENDED CHARTER

 

Management

 

For

 

For

 

3

 

GENERAL RESOLUTIONS

 

Management

 

For

 

For

 

 


 

ILLUMINOSS MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

11-Jan-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

2

 

SERIES AA PREFERRED STOCK PURCHASE AND EXCHANGE AGREEMENT

 

Management

 

For

 

For

 

3

 

WAIVER OF RIGHT OF SUBSCRIPTION RIGHTS

 

Management

 

For

 

For

 

4

 

AMENDMENT TO THE CORPORATION’S 2007 STOCK OPTIONS/STOCK ISSUANCE PLAN

 

Management

 

For

 

For

 

5

 

BLUESKY AGREEMENT

 

Management

 

For

 

For

 

6

 

ELECTION OF DIRECTORS

 

Management

 

For

 

For

 

7

 

GENERAL RESOLUTIONS

 

Management

 

For

 

For

 

 

IMPAX LABORATORIES, INC.

 

Security

 

45256B101

 

 

 

Meeting Type

 

Special

Ticker Symbol

 

IPXL

 

 

 

Meeting Date

 

08-Dec-2015

Record Date

 

26-Oct-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF THE COMPANY’S COMMON STOCK, PAR VALUE $0.01 PER SHARE, FROM 90,000,000 SHARES TO 150,000,000 SHARES.

 

Management

 

For

 

For

 

 

IMPAX LABORATORIES, INC.

 

Security

 

45256B101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

IPXL

 

 

 

Meeting Date

 

17-May-2016

Record Date

 

06-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: LESLIE Z. BENET, PH.D.

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: ROBERT L. BURR

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: ALLEN CHAO, PH.D.

 

Management

 

For

 

For

 

1.4

 

ELECTION OF DIRECTOR: MARY K. PENDERGAST, J.D.

 

Management

 

For

 

For

 

1.5

 

ELECTION OF DIRECTOR: PETER R. TERRERI

 

Management

 

For

 

For

 

1.6

 

ELECTION OF DIRECTOR: JANET S. VERGIS

 

Management

 

For

 

For

 

1.7

 

ELECTION OF DIRECTOR: G. FREDERICK WILKINSON

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE THIRD AMENDMENT AND RESTATEMENT OF OUR 2002 EQUITY INCENTIVE PLAN TO, AMONG OTHER ITEMS, INCREASE THE AGGREGATE NUMBER OF SHARES OF OUR COMMON STOCK THAT MAY BE ISSUED UNDER SUCH PLAN.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY NON-BINDING VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

INCYTE CORPORATION

 

Security

 

45337C102

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

INCY

 

 

 

Meeting Date

 

27-May-2016

Record Date

 

08-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JULIAN C. BAKER

 

 

 

For

 

For

 

 

 

2

JEAN-JACQUES BIENAIME

 

 

 

For

 

For

 

 

 

3

PAUL A. BROOKE

 

 

 

For

 

For

 

 

 

4

PAUL J. CLANCY

 

 

 

For

 

For

 

 

 

5

WENDY L. DIXON

 

 

 

For

 

For

 

 

 

6

PAUL A. FRIEDMAN

 

 

 

For

 

For

 

 

 

7

HERVE HOPPENOT

 

 

 

For

 

For

 

2.

 

TO APPROVE AMENDMENTS TO THE COMPANY’S AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S 1997 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE THEREUNDER BY 500,000 SHARES, FROM 8,350,000 SHARES TO 8,850,000 SHARES.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

5.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2016.

 

Management

 

For

 

For

 

 


 

INOTEK PHARMACEUTICALS CORPORATION

 

Security

 

45780V102

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ITEK

 

 

 

Meeting Date

 

23-Jun-2016

Record Date

 

28-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CARSTEN BOESS

 

 

 

For

 

For

 

 

 

2

J. MARTIN CARROLL

 

 

 

For

 

For

 

 

 

3

GARY M. PHILLIPS, M.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF RSM US LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

INSIGHTRA MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

13-Aug-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

CONSENT TO AMENDMENTS TO CERTIFICATION OF DETERMINATION, ISSUANCE OF SECURITIES AND WAIVER OF ANTI-DILUTION

 

Management

 

For

 

For

 

 

INSIGHTRA MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

29-Oct-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

CONSENT OF ISSUANCE OF SECURITIES AND WAIVER OF FIRST OFFER

 

Management

 

For

 

For

 

 

INSIGHTRA MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

24-Nov-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

CONSENT TO NON-WHOLLY OWNED SUBSIDIARIES

 

Management

 

For

 

For

 

 

INSIGHTRA MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

19-Jan-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

WAIVER OF FIRST OFFER AND WAIVER OF ANTI-DILUTION

 

Management

 

For

 

For

 

 

INSIGHTRA MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

12-Apr-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

CONSENT AND WAIVER OF FIRST OFFER

 

Management

 

For

 

For

 

 

INSMED INCORPORATED

 

Security

 

457669307

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

INSM

 

 

 

Meeting Date

 

19-May-2016

Record Date

 

28-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ALFRED F. ALTOMARI

 

 

 

For

 

For

 

 

 

2

STEINAR J ENGELSEN M.D.

 

 

 

For

 

For

 

 

 

3

WILLIAM H. LEWIS

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR INSMED INCORPORATED FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 


 

INTRA-CELLULAR THERAPIES INC

 

Security

 

46116X101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ITCI

 

 

 

Meeting Date

 

14-Jun-2016

Record Date

 

20-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

SHARON MATES, PH.D.

 

 

 

For

 

For

 

 

 

2

RORY B. RIGGS

 

 

 

For

 

For

 

 

 

3

ROBERT L. VAN NOSTRAND

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

TO APPROVE BY AN ADVISORY VOTE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

4.

 

TO APPROVE BY AN ADVISORY VOTE THE FREQUENCY OF HOLDING AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

1 Year

 

For

 

 

JAZZ PHARMACEUTICALS PLC

 

Security

 

G50871105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

JAZZ

 

 

 

Meeting Date

 

30-Jul-2015

Record Date

 

01-Jun-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: PETER GRAY

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: KENNETH W. O’KEEFE

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: ELMAR SCHNEE

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: CATHERINE A. SOHN

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE APPOINTMENT OF KPMG AS THE INDEPENDENT AUDITORS OF JAZZ PHARMACEUTICALS PLC FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015 AND TO AUTHORIZE THE BOARD OF DIRECTORS, ACTING THROUGH THE AUDIT COMMITTEE, TO DETERMINE THE AUDITORS’ REMUNERATION.

 

Management

 

For

 

For

 

3.

 

TO AUTHORIZE JAZZ PHARMACEUTICALS PLC AND/OR ANY SUBSIDIARY OF JAZZ PHARMACEUTICALS PLC TO MAKE MARKET PURCHASES OF JAZZ PHARMACEUTICALS PLC’S ORDINARY SHARES.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF JAZZ PHARMACEUTICALS PLC’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

 

MAGELLAN BIOSCIENCES, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

23-Mar-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVE SPECIFIED COMPENSATORY ARRANGEMENTS BETWEEN MAGELLAN BIOSCIENCES, INC. AND ITS NAMED EXECUTIVE OFFICERS RELATING TO THE TRANSACTION

 

Management

 

For

 

For

 

 

MAGELLAN BIOSCIENCES, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

24-Mar-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVE THE RECEIPT OF MERGER CONSIDERATION BY VARIOUS INTERESTED ENTITIES AND INDIVIDUALS UNDER SECTION 144 OF THE DELAWARE GENERAL CORPORATION LAW

 

Management

 

For

 

For

 

2

 

APPROVAL OF MERGER AND RELATED TRANSACTIONS

 

Management

 

For

 

For

 

3

 

APPROVAL OF THE STOCKHOLDER REPRESENTATIVE

 

Management

 

For

 

For

 

4

 

WAIVER OF APPRAISAL RIGHTS

 

Management

 

For

 

For

 

5

 

ADDITIONAL AGREEMENTS AND ACKNOWLEDGEMENTS

 

Management

 

For

 

For

 

6

 

WAIVER OF NOTICE REQUIREMENTS

 

Management

 

For

 

For

 

7

 

OMNIBUS RESOLUTIONS

 

Management

 

For

 

For

 

 


 

MEDIVATION, INC.

 

Security

 

58501N101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

MDVN

 

 

 

Meeting Date

 

22-Jun-2016

Record Date

 

25-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KIM D. BLICKENSTAFF

 

 

 

For

 

For

 

 

 

2

KATHRYN E. FALBERG

 

 

 

For

 

For

 

 

 

3

DAVID T. HUNG, M.D.

 

 

 

For

 

For

 

 

 

4

MICHAEL L. KING, PH.D.

 

 

 

For

 

For

 

 

 

5

C. PATRICK MACHADO

 

 

 

For

 

For

 

 

 

6

DAWN SVORONOS

 

 

 

For

 

For

 

 

 

7

W. ANTHONY VERNON

 

 

 

For

 

For

 

 

 

8

WENDY L. YARNO

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS MEDIVATION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF MEDIVATION’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT OF MEDIVATION.

 

Management

 

For

 

For

 

4.

 

TO APPROVE AN AMENDMENT AND RESTATEMENT OF THE MEDIVATION, INC. AMENDED AND RESTATED 2004 EQUITY INCENTIVE AWARD PLAN TO INCREASE THE NUMBER OF SHARES OF MEDIVATION’S COMMON STOCK RESERVED FOR ISSUANCE UNDER THE PLAN BY 1,600,000 SHARES AND MAKE CERTAIN OTHER CHANGES AS DESCRIBED IN PROPOSAL NO. 4 IN THE PROXY STATEMENT OF MEDIVATION.

 

Management

 

For

 

For

 

5.

 

THE SHAREHOLDER PROPOSAL REGARDING PROXY ACCESS, IF PROPERLY PRESENTED AT THE ANNUAL MEETING.

 

Shareholder

 

Against

 

For

 

 

MERRIMACK PHARMACEUTICALS, INC.

 

Security

 

590328100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

MACK

 

 

 

Meeting Date

 

14-Jun-2016

Record Date

 

19-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. MULROY

 

 

 

For

 

For

 

 

 

2

GARY L. CROCKER

 

 

 

For

 

For

 

 

 

3

JOHN M. DINEEN

 

 

 

For

 

For

 

 

 

4

VIVIAN S. LEE, M.D. PHD

 

 

 

For

 

For

 

 

 

5

JOHN MENDELSOHN, M.D.

 

 

 

For

 

For

 

 

 

6

ULRIK B. NIELSEN, PH.D.

 

 

 

For

 

For

 

 

 

7

MICHAEL E. PORTER, PH.D

 

 

 

For

 

For

 

 

 

8

JAMES H. QUIGLEY

 

 

 

For

 

For

 

 

 

9

RUSSELL T. RAY

 

 

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

24-Sep-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

ADJUST THE EXERCISE PRICE OF THE OPTIONS UNDER THE OPTION PLAN 2010 AND REFUND ANY DIFFERENCES IN EXERCISE PRICE OF THE OPTIONS TO PARTICIPANTS

 

Management

 

For

 

For

 

 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

14-Oct-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

GRANT OPTIONS UNDER THE MERUS B.V. 2010 OPTION PLAN AND SET THE EXERCISE PRICE FOR EACH OPTION

 

Management

 

For

 

For

 

 


 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

22-Dec-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVE PUBLICATION OF THE ANNUAL ACCOUNTS AND THE DIRECTOR’S REPORT IN THE ENGLISH LANGUAGE

 

Management

 

For

 

For

 

2

 

ADOPT THE 2014 ANNUAL ACCOUNTS

 

Management

 

For

 

For

 

3

 

APPROVE TREATMENT OF LOSS CHARGED TO RESERVES

 

Management

 

For

 

For

 

4

 

APPROVE DISCHARGE OF MANAGEMENT BOARD FOR FISCAL 2014

 

Management

 

For

 

For

 

5

 

APPROVE DISCHARGE OF SUPERVISORY BOARD FOR FISCAL 2014

 

Management

 

For

 

For

 

6

 

APPROVE ANNUAL COMPENSATION TO CERTAIN NAMED INDEPENDENT DIRECTORS

 

Management

 

For

 

For

 

7

 

APPROVE GRANTS OF OPTIONS TO INDEPENDENT DIRECTORS

 

Management

 

For

 

For

 

8

 

APPROVE RENUMERATION OF AUDIT COMMITTEE CHAIRMAN

 

Management

 

For

 

For

 

9

 

APPROVE RENUMERATION OF COMPENSATION COMMITTEE CHAIRMAN

 

Management

 

For

 

For

 

10

 

RESOLVE THAT SUCH OPTIONS AND ANNUAL COMPENSATION IN CASH WHICH HAVE NOT YET BEEN GRANTED, SHALL LAPSE WITH IMMEDIATE EFFECT UPON THE EFFECTIVENESS OF THE 2015 PLAN.

 

Management

 

For

 

For

 

 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

08-Jan-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

CONSENT TO SEND YOU THE CONVOCATION INCLUDING ALL NECESSARY INFORMATION FOR THE SHAREHOLDERS MEETINGS (GENERAL MEETING AND PREFERRED MEETING), WITHOUT TAKING INTO ACCOUNT THE CONVOCATION REQUIREMENTS, AS LONG AS THE MEETINGS ARE SCHEDULED IN 2016

 

Management

 

For

 

For

 

2

 

CONSENT TO DECIDING ON SUCH MATTERS BY WRITTEN RESOLUTION OUTSIDE A MEETING, AS AN ALTERNATIVE FOR OPTION 1, IF THE COMPANY DECIDES TO DO SO FOR PRACTICAL REASONS

 

Management

 

For

 

For

 

 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

02-Mar-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

RESOLUTION TO ISSUE OPTION SHARES UNDER THE MERUS B.V. 2010 EMPLOYEE OPTION PLAN

 

Management

 

For

 

For

 

2

 

RESOLUTION TO EXCLUDE PRE-EMPTIVE RIGHTS

 

Management

 

For

 

For

 

 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

21-Mar-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

GRANT INITIAL EQUITY AWARDS TO SELECT INDEPENDENT DIRECTORS AND ESTABLISH DATE OF GRANT, VESTING COMMENCEMENT DATE AND THE EXERCISE PRICE

 

Management

 

For

 

For

 

 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

03-May-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

ADOPT THE 2015 ACCOUNTS

 

Management

 

For

 

For

 

2

 

APPROVE TREATMENT OF LOSS CHARGED TO RESERVES

 

Management

 

For

 

For

 

3

 

APPROVE DISCHARGE OF MANAGEMENT BOARD FOR FISCAL 2015

 

Management

 

For

 

For

 

4

 

APPROVE DISCHARGE OF SUPERVISORY BOARD FOR FISCAL 2015

 

Management

 

For

 

For

 

 


 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

06-May-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVE THE AMENDMENT OF THE ARTICLES OF ASSOCIATION AND TO EFFECT A REVERSE STOCK SPLIT

 

Management

 

For

 

For

 

2

 

APPROVE THE CONVERSION OF THE COMPANY INTO A PUBLIC LIMITED LIABILITY COMPANY AND AMEND THE ARTICLES OF ASSOCIATION

 

Management

 

For

 

For

 

3

 

APPROVE ISSUANCE OF COMMON SHARES

 

Management

 

For

 

For

 

4

 

APPROVE THE CONVERSION OF ALL ISSUED PREFERRED SHARES INTO COMMMON SHARES

 

Management

 

For

 

For

 

5

 

APPROVE RENUMERATION OF THE SUPERVISORY BOARD

 

Management

 

For

 

For

 

6A

 

APPROVE ANY REQUIRED APPLICATION TO NASDAQ

 

Management

 

For

 

For

 

6B

 

APPROVE OF THE COMPANY PERFORMING ALL ACTS AS THE MANAGEMENT BOARD DEEMS NECESSARY IN CONNECTION WITH OR CONDUCIVE TO THE CONVERSION AND/OR IPO

 

Management

 

For

 

For

 

6C

 

APPROVE THE COMPANY RATIFYING AND CONFIRMING ANY DOCUMENT, DEED OR INSTRUMENT ALREADY EXECUTED IN RELATION TO THE CONVERSION AND/OR THE IPO

 

Management

 

For

 

For

 

6D

 

APPROVE THE TRANSFER OF THE SHARES TO SHAREHOLDERS OF CEDE & CO AFTER THE END OF THE LOCK-UP PERIOD BASED ON THE LOCK-UP AGREEMENT, IF APPLICABLE

 

Management

 

For

 

For

 

7

 

WAIVE ANY AND ALL PRE-EMPTIVE RIGHTS AND/OR ANTI-DILUTION PROTECTION IN RELATION TO ANY ISSUANCE OF COMMON SHARES AND/OR GRANTING RIGHTS TO SUBSCRIBE TO SHARES IN THE COMPANY’S SHARE CAPITAL

 

Management

 

For

 

For

 

9

 

WAIVE ANY RIGHT OF FIRST REFUSAL THE PREFERRED SHAREHOLDERS MAY HAVE AND TO APPROVE SUCH TRANSFER

 

Management

 

For

 

For

 

 

MERUS B.V.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

06-May-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVE THE LISTING OF THE COMPANY’S SHARES AT THE NASDAQ GLOBAL MARKET

 

Management

 

For

 

For

 

2

 

APPROVE A REVERSE STOCK SPLIT

 

Management

 

For

 

For

 

3

 

APPROVE THE CONVERSION OF THE COMPANY INTO A PUBLIC LIMITED LIABILITY COMPANY

 

Management

 

For

 

For

 

4

 

APPROVE THE ISSUANCE OF A NUMBER OF COMMON SHARES IN THE SHARE CAPITAL OF THE COMPANY TO THE PARTIES AND IN ACCORDANCE WITH THE NOTARIAL DEED OF ISSUE

 

Management

 

For

 

For

 

5

 

DELEGATE, TO THE MANAGEMENT BOARD, CERTAIN AUTHORITY TO ISSUE NEW SHARES AND GRANT RIGHTS

 

Management

 

For

 

For

 

6A

 

APPROVE RESTRICTION AND/OR EXCLUSION OF PRE-EMPTIVE RIGHTS

 

Management

 

For

 

For

 

6B

 

REPURCHASE SHARES IN THE CAPITAL OF THE COMPANY

 

Management

 

For

 

For

 

7A

 

THE RIGHT TO SUBSCRIBE FOR A NUMBER OF PREFERRED SHARES IN THE COMPANY’S SHARE CAPITAL TO STICHTING CONTINUITEIT MERUS AND APPROVE THE ENTERING INTO A CALL OPTION AGREEMENT

 

Management

 

For

 

For

 

7B

 

APPROVE THAT THE MANAGEMENT BOARD SHALL PROVIDE A LOAN TO THE FOUNDATION FOR ITS PAYMENT OBLIGATIONS IN RELATION TO THE CALL OPTION

 

Management

 

For

 

For

 

8

 

DISMISS OR REAPPOINT CERTAIN MEMBERS OF THE SUPERVISORY BOARD

 

Management

 

For

 

For

 

9

 

ADOPT THE COMPANY’S POLICY CONCERNING THE COMPENSATION OF THE MEMBERS OF THE MANAGEMENT BOARD

 

Management

 

For

 

For

 

10

 

ADOPT THE COMPANY’S 2016 INCENTIVE AWARD PLAN

 

Management

 

For

 

For

 

11

 

APPROVE REMUNERATION OF SUPERVISORY BOARD

 

Management

 

For

 

For

 

12

 

APPROVE THE PROPOSAL OF THE MANAGEMENT BOARD TO DELETE CLAUSE 7.3 OF THE MERUS B.V. 2010 EMPLOYEE OPTION PLAN

 

Management

 

For

 

For

 

13.A

 

CANCEL 1,000 COMMON SHARES IN THE CAPITAL OF THE COMPANY HELD BY STICHTING ADMINISTRATIEKANTOOR MERUS

 

Management

 

For

 

For

 

13.B

 

CANCEL 225 COMMON SHARES IN THE CAPITAL OF THE COMPANY HELD BY STICHTING ADMINISTRATIEKANTOOR MERUS

 

Management

 

For

 

For

 

14

 

CONSENT TO SEND ALL INFORMATION TO THE SHAREHOLDERS BY ELECTRONIC MEANS

 

Management

 

For

 

For

 

15

 

DETERMINE THAT THE SHAREHOLDER’S AGREEMENT SHALL TERMINATE AS PER THE EFFECTIVENESS OF THE REGISTRATION STATEMENT (WHETHER THE IPO QUALIFIES AS A QUALIFYING IPO AS DEFINED IN THE SHAREHOLDERS AGREEMENT OR NOT)

 

Management

 

For

 

For

 

 


 

MYLAN N.V.

 

Security

 

N59465109

 

 

 

Meeting Type

 

Special

Ticker Symbol

 

MYL

 

 

 

Meeting Date

 

28-Aug-2015

Record Date

 

31-Jul-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

APPROVAL UNDER ARTICLE 2:107A OF THE DUTCH CIVIL CODE OF THE ACQUISITION, DIRECTLY OR INDIRECTLY (WHETHER BY WAY OF AN OFFER (AND SUBSEQUENT COMPULSORY ACQUISITION) OR ANY OTHER LEGAL ARRANGEMENT) OF ALL OR ANY PORTION OF THE ORDINARY SHARES OF PERRIGO COMPANY PLC (“PERRIGO”) OUTSTANDING (ON A FULLY DILUTED ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL).

 

Management

 

Against

 

Against

 

 

NATERA, INC.

 

Security

 

632307104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

NTRA

 

 

 

Meeting Date

 

07-Jun-2016

Record Date

 

19-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JAMES I. HEALY

 

 

 

For

 

For

 

 

 

2

EDWARD C. DRISCOLL, JR.

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

NEUROCRINE BIOSCIENCES, INC.

 

Security

 

64125C109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

NBIX

 

 

 

Meeting Date

 

20-May-2016

Record Date

 

12-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CORINNE H. NEVINNY

 

 

 

For

 

For

 

 

 

2

RICHARD F. POPS

 

 

 

For

 

For

 

 

 

3

STEPHEN SHERWIN, M.D.

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE FROM 110,000,000 TO 220,000,000.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE COMPANY’S 2011 EQUITY INCENTIVE PLAN, AS AMENDED.

 

Management

 

For

 

For

 

5.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

11-Nov-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVAL THAT THE TERMS AND CONDITIONS OF THE TERM SHEET, ARE JUST, EQUITABLE AND FAIR

 

Management

 

For

 

For

 

2

 

APPROVAL FOR THE COMPANY TO ENTER INTO A TERM SHEET WITH H.I.G. BIOVENTURES, LLC FOR A SERIES B PREFERRED STOCK FINANCING.

 

Management

 

For

 

For

 

 


 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

09-Dec-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

INCREASE THE SIZE OF THE COMPANY’S BOARD TO SEVEN (7) MEMBERS

 

Management

 

For

 

For

 

2

 

APPROVE THE BOARD’S EXPANSION OF THE COMPANY’S BOARD OF DIRECTORS TO SEVEN (7) DIRECTORS; AND OF THE ELECTION OF MR. BAILEY TO FILL THE VACANCY CREATED CREATED BY THAT EXPANSION

 

Management

 

For

 

For

 

3

 

APPROVE OF THE BOARD’S HAVING AUTHORIZED AND DIRECTED THAT THE COMPANY SHOULD ENTER INTO A CONSULTING AGREEMENT; AS WELL AS AN ASSOCIATED, NONQUALIFIED STOCK OPTION FOR SHARES OF COMMON STOCK UNDER THE COMPANY’S 2011 EQUITY INCENTIVE PLAN

 

Management

 

For

 

For

 

4

 

AUTHORIZE, EMPOWER AND DIRECT THE CHIEF EXECUTIVE OFFICER TO TAKE ANY AND ALL ACTIONS SUCH OFFICER DEEMS NECESSARY OR APPROPRIATE TO IMPLEMENT THE FOREGOING RESOLUTIONS

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

22-Feb-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

BRIDGE FINANCING

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

29-Feb-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

SECOND CLOSING MAJORITY FOR BRIDGE FINANCING

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

27-Jun-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

BRIDGE FINANCING

 

Management

 

For

 

For

 

 

NEVRO CORP.

 

Security

 

64157F103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

NVRO

 

 

 

Meeting Date

 

18-May-2016

Record Date

 

23-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ALI BEHBAHANI, M.D.

 

 

 

For

 

For

 

 

 

2

RAMI ELGHANDOUR

 

 

 

For

 

For

 

 

 

3

WILFRED E. JAEGER, M.D.

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION, BY THE AUDIT COMMITTEE OF THE COMPANY’S BOARD OF DIRECTORS, OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2016

 

Management

 

For

 

For

 

3.

 

TO RECOMMEND, ON A NON-BINDING, ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS

 

Management

 

1 Year

 

For

 

 

NOVAVAX, INC.

 

Security

 

670002104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

NVAX

 

 

 

Meeting Date

 

09-Jun-2016

Record Date

 

13-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

GAIL K. BOUDREAUX

 

 

 

For

 

For

 

 

 

2

MICHAEL A. MCMANUS, JR.

 

 

 

For

 

For

 

 

 

3

JAMES F. YOUNG

 

 

 

For

 

For

 

2.

 

TO AMEND AND RESTATE THE NOVAVAX, INC. 2015 STOCK INCENTIVE PLAN AND TO INCREASE THE NUMBER OF SHARES OF THE COMPANY’S COMMON STOCK, PAR VALUE $0.01, AVAILABLE FOR ISSUANCE THEREUNDER BY 6,000,000 SHARES.

 

Management

 

For

 

For

 

3.

 

TO AMEND AND RESTATE THE NOVAVAX, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN AND TO INCREASE THE NUMBER OF SHARES OF THE COMPANY’S COMMON STOCK, PAR VALUE $0.01, AVAILABLE FOR ISSUANCE THEREUNDER BY 1,000,000 SHARES.

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 


 

PARATEK PHARMACEUTICALS, INC.

 

Security

 

699374302

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

PRTK

 

 

 

Meeting Date

 

08-Jun-2016

Record Date

 

11-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

THOMAS J. DIETZ, PH.D.

 

 

 

For

 

For

 

 

 

2

EVAN LOH, M.D.

 

 

 

For

 

For

 

 

 

3

TIMOTHY R. FRANSON, M.D

 

 

 

For

 

For

 

2.

 

PROPOSAL WITHDRAWN

 

Management

 

Abstain

 

 

 

3.

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

PIERIS PHARMACEUTICALS INC

 

Security

 

720795103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

PIRS

 

 

 

Meeting Date

 

28-Jun-2016

Record Date

 

06-May-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CHAU KHUONG

 

 

 

For

 

For

 

 

 

2

STEVEN PRELACK

 

 

 

For

 

For

 

2.

 

PROPOSAL TO APPROVE THE COMPANY’S 2016 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

REGENERON PHARMACEUTICALS, INC.

 

Security

 

75886F107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

REGN

 

 

 

Meeting Date

 

10-Jun-2016

Record Date

 

14-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: MICHAEL S. BROWN

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: LEONARD S. SCHLEIFER

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: GEORGE D. YANCOPOULOS

 

Management

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

RETROPHIN, INC.

 

Security

 

761299106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

RTRX

 

 

 

Meeting Date

 

18-May-2016

Record Date

 

23-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

STEPHEN ASELAGE

 

 

 

For

 

For

 

 

 

2

TIM COUGHLIN

 

 

 

For

 

For

 

 

 

3

CORNELIUS E. GOLDING

 

 

 

For

 

For

 

 

 

4

JOHN KOZARICH

 

 

 

For

 

For

 

 

 

5

GARY LYONS

 

 

 

For

 

For

 

 

 

6

JEFFREY MECKLER

 

 

 

For

 

For

 

2

 

TO APPROVE THE COMPANY’S 2015 EQUITY INCENTIVE PLAN, AS AMENDED, TO, AMONG OTHER ITEMS, INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE THEREUNDER BY 1,600,000.

 

Management

 

For

 

For

 

3

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4

 

TO RATIFY THE SELECTION OF BDO USA LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 


 

REVANCE THERAPEUTICS, INC.

 

Security

 

761330109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

RVNC

 

 

 

Meeting Date

 

05-May-2016

Record Date

 

11-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

RONALD W. EASTMAN

 

 

 

For

 

For

 

 

 

2

MARK A. PRYGOCKI

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

SAGE THERAPEUTICS, INC.

 

Security

 

78667J108

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

SAGE

 

 

 

Meeting Date

 

22-Jun-2016

Record Date

 

25-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: KEVIN P. STARR

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: JAMES FRATES

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

ADVISORY VOTE ON THE FREQUENCY OF ADVISORY VOTES ON EXECUTIVE COMPENSATION.

 

Management

 

1 Year

 

For

 

 

SHIRE PLC

 

Security

 

82481R106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

SHPG

 

 

 

Meeting Date

 

28-Apr-2016

Record Date

 

18-Mar-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

TO RECEIVE THE COMPANY’S ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED DECEMBER 31, 2015.

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE DIRECTORS’ REMUNERATION REPORT, EXCLUDING THE DIRECTORS’ REMUNERATION POLICY, SET OUT ON PAGES 76 TO 101 OF THE ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO RE-ELECT DOMINIC BLAKEMORE AS A DIRECTOR.

 

Management

 

For

 

For

 

4.

 

TO ELECT OLIVIER BOHUON AS A DIRECTOR.

 

Management

 

For

 

For

 

5.

 

TO RE-ELECT WILLIAM BURNS AS A DIRECTOR.

 

Management

 

For

 

For

 

6.

 

TO RE-ELECT DR. STEVEN GILLIS AS A DIRECTOR.

 

Management

 

For

 

For

 

7.

 

TO RE-ELECT DR. DAVID GINSBURG AS A DIRECTOR.

 

Management

 

For

 

For

 

8.

 

TO RE-ELECT SUSAN KILSBY AS A DIRECTOR.

 

Management

 

For

 

For

 

9.

 

TO ELECT SARA MATHEW AS A DIRECTOR.

 

Management

 

For

 

For

 

10.

 

TO RE-ELECT ANNE MINTO AS A DIRECTOR.

 

Management

 

For

 

For

 

11.

 

TO RE-ELECT DR. FLEMMING ORNSKOV AS A DIRECTOR.

 

Management

 

For

 

For

 

12.

 

TO ELECT JEFFREY POULTON AS A DIRECTOR.

 

Management

 

For

 

For

 

13.

 

TO RE-APPOINT DELOITTE LLP AS THE COMPANY’S AUDITOR UNTIL THE CONCLUSION OF THE NEXT ANNUAL GENERAL MEETING OF THE COMPANY.

 

Management

 

For

 

For

 

14.

 

TO AUTHORIZE THE AUDIT, COMPLIANCE & RISK COMMITTEE TO DETERMINE THE REMUNERATION OF THE AUDITOR.

 

Management

 

For

 

For

 

15.

 

THAT THE AUTHORITY TO ALLOT RELEVANT SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION (THE “ARTICLES”)) CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (B) OF THE ARTICLES BE RENEWED AND FOR THIS PURPOSE THE AUTHORISED ALLOTMENT AMOUNT SHALL BE: (A)  9,886,710.20 OF RELEVANT SECURITIES; AND (B) SOLELY IN CONNECTION WITH AN ALLOTMENT PURSUANT TO AN OFFER BY WAY OF A RIGHTS ISSUE (AS DEFINED IN THE ARTICLES, BUT ONLY IF AND TO THE EXTENT THAT SUCH OFFER IS ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

16.

 

THAT, SUBJECT TO THE PASSING OF RESOLUTION 15, THE AUTHORITY TO ALLOT EQUITY SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION (THE “ARTICLES”)) WHOLLY FOR CASH CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (D) OF THE ARTICLES BE RENEWED AND FOR THIS PURPOSE THE NON PRE-EMPTIVE AMOUNT (AS DEFINED IN THE ARTICLES) SHALL BE 3,005,870.30 AND THE ALLOTMENT PERIOD SHALL BE THE PERIOD COMMENCING ON APRIL 28, 2016, AND ENDING ON THE EARLIER OF JULY 27, 2017, ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

17.

 

THAT THE COMPANY BE AND IS HEREBY GENERALLY AND UNCONDITIONALLY AUTHORIZED: (A) PURSUANT TO ARTICLE 57 OF THE COMPANIES (JERSEY) LAW 1991 TO MAKE MARKET PURCHASES OF ORDINARY SHARES IN THE CAPITAL OF THE COMPANY, PROVIDED THAT: (1) THE MAXIMUM NUMBER OF ORDINARY SHARES HEREBY AUTHORIZED TO BE PURCHASED IS 59,320,261; (2) THE MINIMUM PRICE, EXCLUSIVE OF ANY EXPENSES, WHICH MAY BE PAID FOR AN ORDINARY SHARE IS FIVE PENCE; (3) THE MAXIMUM PRICE, EXCLUSIVE OF ANY EXPENSES, WHICH MAY BE PAID ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

18.

 

THAT THE AUTHORIZED SHARE CAPITAL OF THE COMPANY BE INCREASED FROM 50,000,002 TO 75,000,002, TO BE DIVIDED INTO 1,500,000,000 SHARES DESIGNATED AS ORDINARY SHARES WITH A PAR VALUE OF 5P EACH AND 2 SHARES DESIGNATED AS SUBSCRIBER ORDINARY SHARES WITH A PAR VALUE OF 1 EACH, AND THAT THE COMPANY’S MEMORANDUM OF ASSOCIATION BE AMENDED ACCORDINGLY.

 

Management

 

For

 

For

 

19.

 

THAT, WITH EFFECT FROM THE CONCLUSION OF THE ANNUAL GENERAL MEETING, THE COMPANY’S ARTICLES OF ASSOCIATION BE AMENDED AND THOSE ARTICLES PRODUCED TO THE MEETING AND INITIALED BY THE CHAIRMAN BE ADOPTED AS THE COMPANY’S ARTICLES OF ASSOCIATION, IN SUBSTITUTION FOR, AND TO THE EXCLUSION OF, THE EXISTING ARTICLES OF ASSOCIATION OF THE COMPANY.

 

Management

 

For

 

For

 

20.

 

TO APPROVE THAT A GENERAL MEETING OF THE COMPANY, OTHER THAN AN ANNUAL GENERAL MEETING, MAY BE CALLED ON NOT LESS THAN 14 CLEAR DAYS’ NOTICE.

 

Management

 

For

 

For

 

 


 

SHIRE PLC

 

Security

 

82481R106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

SHPG

 

 

 

Meeting Date

 

27-May-2016

Record Date

 

21-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF THE MERGER, ALLOTMENT OF SHARES AND INCREASE IN BORROWING LIMIT THAT: (A) THE PROPOSED COMBINATION BY THE COMPANY, THROUGH ITS WHOLLY-OWNED SUBSIDIARY, BEARTRACKS, INC., WITH THE OUTSTANDING COMMON STOCK WITH BAXALTA INC. (THE “MERGER”), ON THE TERMS AND CONDITIONS SET OUT IN THE MERGER AGREEMENT (AS DEFINED IN, AND PARTICULARS OF WHICH ARE SUMMARISED IN, THE CIRCULAR OF THE COMPANY DATED 18 APRIL 2016), TOGETHER WITH ALL OTHER AGREEMENTS AND ANCILLARY ARRANGEMENTS ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

2

 

AUTHORITY TO ALLOT SHARES THAT, SUBJECT TO AND CONDITIONAL UPON THE MERGER HAVING BEEN IMPLEMENTED AND THE NEW ORDINARY SHARES IN THE COMPANY HAVING BEEN ISSUED PURSUANT THERETO, ANY PREVIOUS AUTHORITY TO ALLOT RELEVANT SECURITIES (AS DEFINED IN THE ARTICLES), CONFERRED ON THE DIRECTORS BY SHAREHOLDERS PURSUANT TO ARTICLE 10 OF THE ARTICLES (INCLUDING ANY UNUSED AUTHORITY CONFERRED BY RESOLUTION 1 ABOVE) BE CANCELLED AND THE AUTHORITY TO ALLOT RELEVANT SECURITIES CONFERRED ON THE ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

3

 

DISAPPLICATION OF PRE-EMPTION RIGHTS: THAT, SUBJECT TO THE PASSING OF RESOLUTION 2 AND SUBJECT TO AND CONDITIONAL UPON THE MERGER HAVING BEEN IMPLEMENTED AND THE NEW ORDINARY SHARES IN THE COMPANY HAVING BEEN ISSUED PURSUANT THERETO, ANY PREVIOUS AUTHORITY TO ALLOT EQUITY SECURITIES (AS DEFINED IN THE ARTICLES) WHOLLY FOR CASH CONFERRED ON THE DIRECTORS BY SHAREHOLDERS PURSUANT TO ARTICLE 10 OF THE ARTICLES OF ASSOCIATION BE CANCELLED AND THE AUTHORITY TO ALLOT EQUITY ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

4

 

PURCHASE OF OWN SHARES: THAT, SUBJECT TO AND CONDITIONAL UPON THE MERGER HAVING BEEN IMPLEMENTED AND THE NEW ORDINARY SHARES IN THE COMPANY HAVING BEEN ISSUED PURSUANT THERETO, ANY PREVIOUS AUTHORITY CONFERRED ON THE COMPANY TO MAKE MARKET PURCHASES OF ITS SHARES AND TO HOLD TREASURY SHARES BE CANCELLED AND THE COMPANY BE GENERALLY AND UNCONDITIONALLY AUTHORISED: (A) PURSUANT TO ARTICLE 57 OF THE COMPANIES (JERSEY) LAW 1991 TO MAKE MARKET PURCHASES OF ORDINARY SHARES IN THE ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

 


 

TETRAPHASE PHARMACEUTICALS, INC.

 

Security

 

88165N105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

TTPH

 

 

 

Meeting Date

 

08-Jun-2016

Record Date

 

14-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

GAREN BOHLIN

 

 

 

For

 

For

 

 

 

2

JOHN FREUND

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, OUR EXECUTIVE COMPENSATION

 

Management

 

For

 

For

 

4.

 

TO RECOMMEND, ON AN ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION

 

Management

 

1 Year

 

For

 

 

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

 

Security

 

881624209

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

TEVA

 

 

 

Meeting Date

 

03-Sep-2015

Record Date

 

04-Aug-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A

 

ELECTION OF DIRECTOR: ROGER ABRAVANEL

 

Management

 

For

 

For

 

1B

 

ELECTION OF DIRECTOR: ROSEMARY A. CRANE

 

Management

 

For

 

For

 

1C

 

ELECTION OF DIRECTOR: GERALD M. LIEBERMAN

 

Management

 

For

 

For

 

1D

 

ELECTION OF DIRECTOR: GALIA MAOR

 

Management

 

For

 

For

 

2

 

TO APPOINT GABRIELLE GREENE-SULZBERGER TO SERVE AS A STATUTORY INDEPENDENT DIRECTOR FOR A TERM OF THREE YEARS, COMMENCING FOLLOWING THE MEETING, AND TO APPROVE HER REMUNERATION AND BENEFITS.

 

Management

 

For

 

For

 

3A

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S COMPENSATION POLICY WITH RESPECT TO DIRECTOR REMUNERATION.

 

Management

 

For

 

For

 

3A1

 

DO YOU HAVE A “PERSONAL INTEREST” IN PROPOSAL 3A? NOTE: PROPOSAL 3A1, FOR=YES AGAINST=NO

 

Management

 

Against

 

 

 

3B

 

TO APPROVE THE REMUNERATION TO BE PROVIDED TO THE COMPANY’S DIRECTORS.

 

Management

 

For

 

For

 

3C

 

TO APPROVE THE REMUNERATION TO BE PROVIDED TO PROF. YITZHAK PETERBURG, CHAIRMAN OF THE BOARD OF DIRECTORS.

 

Management

 

For

 

For

 

4A

 

TO APPROVE AN AMENDMENT TO THE TERMS OF OFFICE AND EMPLOYMENT OF THE COMPANY’S PRESIDENT AND CHIEF EXECUTIVE OFFICER, MR. EREZ VIGODMAN.

 

Management

 

For

 

For

 

4B

 

TO APPROVE THE PAYMENT OF A SPECIAL BONUS TO THE COMPANY’S PRESIDENT AND CHIEF EXECUTIVE OFFICER, MR. EREZ VIGODMAN.

 

Management

 

For

 

For

 

5

 

TO APPROVE THE COMPANY’S 2015 LONG-TERM EQUITY-BASED INCENTIVE PLAN.

 

Management

 

For

 

For

 

6

 

TO APPOINT KESSELMAN & KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL THE 2016 ANNUAL MEETING OF SHAREHOLDERS.

 

Management

 

For

 

For

 

 


 

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

 

Security

 

881624209

 

 

 

Meeting Type

 

Special

Ticker Symbol

 

TEVA

 

 

 

Meeting Date

 

05-Nov-2015

Record Date

 

06-Oct-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF THE CREATION OF A NEW CLASS OF MANDATORY CONVERTIBLE PREFERRED SHARES, NOMINAL (PAR) VALUE NIS 0.1 PER SHARE AND THE DEFINITION OF THEIR TERMS, AND CERTAIN RELATED AMENDMENTS TO TEVA’S ARTICLES OF ASSOCIATION AND MEMORANDUM OF ASSOCIATION.

 

Management

 

For

 

For

 

 

THE MEDICINES COMPANY

 

Security

 

584688105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

MDCO

 

 

 

Meeting Date

 

26-May-2016

Record Date

 

15-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: WILLIAM W. CROUSE

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: JOHN C. KELLY

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: HIROAKI SHIGETA

 

Management

 

For

 

For

 

2.

 

APPROVE AN AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO PROVIDE FOR THE PHASED DECLASSIFICATION OF OUR BOARD OF DIRECTORS TO BE COMPLETED UPON THE ELECTION OF DIRECTORS AT OUR 2018 ANNUAL MEETING OF STOCKHOLDERS.

 

Management

 

For

 

For

 

3.

 

APPROVE THE 2013 STOCK INCENTIVE PLAN, AS AMENDED, TO INCREASE THE NUMBER OF AUTHORIZED SHARES.

 

Management

 

For

 

For

 

4.

 

APPROVE THE 2010 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED, TO INCREASE THE NUMBER OF AUTHORIZED SHARES.

 

Management

 

For

 

For

 

5.

 

APPROVE, IN AN ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS PRESENTED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

6.

 

RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 

THEROX, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

20-Apr-2016

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF REVERSE STOCK SPLIT

 

Management

 

For

 

For

 

 

TROVAGENE, INC

 

Security

 

897238309

 

 

 

Meeting Type

 

Special

Ticker Symbol

 

TROV

 

 

 

Meeting Date

 

23-Dec-2015

Record Date

 

12-Oct-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

PROPOSAL TO ADOPT AN AMENDMENT TO THE TROVAGENE INC. 2014 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES RESERVED FOR ISSUANCE THEREUNDER TO 7,500,000 FROM 5,000,000.

 

Management

 

For

 

For

 

 

ULTRAGENYX PHARMACEUTICAL INC.

 

Security

 

90400D108

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

RARE

 

 

 

Meeting Date

 

09-Jun-2016

Record Date

 

12-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: WILLIAM ALISKI

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: LARS EKMAN, M.D., PH.D.

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: MATTHEW K. FUST

 

Management

 

For

 

For

 

2.

 

RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPANY’S EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

ADVISORY (NON-BINDING) VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE EXECUTIVE COMPENSATION.

 

Management

 

1 Year

 

For

 

 


 

VENITI, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

04-Dec-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

INCREASE IN SIZE OF BOARD; AMENDMENT OF VOTING AGREEMENT

 

Management

 

For

 

For

 

2

 

INCREASE IN 2010 EQUITY INCENTIVE PLAN

 

Management

 

For

 

For

 

3

 

OMNIBUS RESOLUTIONS

 

Management

 

For

 

For

 

 

VERTEX PHARMACEUTICALS INCORPORATED

 

Security

 

92532F100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

VRTX

 

 

 

Meeting Date

 

15-Jun-2016

Record Date

 

20-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOSHUA BOGER

 

 

 

For

 

For

 

 

 

2

TERRENCE C. KEARNEY

 

 

 

For

 

For

 

 

 

3

YUCHUN LEE

 

 

 

For

 

For

 

 

 

4

ELAINE S. ULLIAN

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

3.

 

ADVISORY VOTE ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

4.

 

SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE TAKE NECESSARY STEPS TO DECLASSIFY OUR BOARD OF DIRECTORS.

 

Shareholder

 

Against

 

For

 

5.

 

SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE ADOPT A POLICY LIMITING ACCELERATION OF EQUITY AWARDS TO SENIOR EXECUTIVES UPON A CHANGE OF CONTROL.

 

Shareholder

 

Against

 

For

 

6.

 

SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE ADOPT A POLICY REQUIRING THAT SENIOR EXECUTIVES RETAIN A PERCENTAGE OF THEIR EQUITY AWARDS.

 

Shareholder

 

Against

 

For

 

7.

 

SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING A REPORT ASSESSING THE FEASIBILITY OF INTEGRATING SUSTAINABILITY INTO PERFORMANCE MEASURES FOR SENIOR EXECUTIVE COMPENSATION.

 

Shareholder

 

Against

 

For

 

 

XENCOR INC

 

Security

 

98401F105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

XNCR

 

 

 

Meeting Date

 

23-Jun-2016

Record Date

 

26-Apr-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DR. BRUCE L.A. CARTER

 

 

 

For

 

For

 

 

 

2

ROBERT BALTERA, JR

 

 

 

For

 

For

 

 

 

3

DR. BASSIL I. DAHIYAT

 

 

 

For

 

For

 

 

 

4

KURT GUSTAFSON

 

 

 

For

 

For

 

 

 

5

YUJIRO S. HATA

 

 

 

For

 

For

 

 

 

6

DR. A. BRUCE MONTGOMERY

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY RSM US, LLP AS THE INDEPENDENT PUBLIC ACCOUNTING FIRM FOR 2016.

 

Management

 

For

 

For

 

 

ZAFGEN, INC.

 

Security

 

98885E103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ZFGN

 

 

 

Meeting Date

 

30-Jun-2016

Record Date

 

02-May-2016

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed By

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: PETER BARRETT, PH.D.

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: FRANCES K. HELLER

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: BRUCE BOOTH, PH.D.

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016.

 

Management

 

For

 

For

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)

Tekla Life Sciences Investors

 

 

By (Signature and Title)*

 

 

 

 

/s/ Daniel R. Omstead

 

(Daniel R. Omstead, President)

 

 

Date

8/29/16

 

*Print the name and title of each signing officer under his or her signature.

 

2